Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	phosphatidylinositol 3-kinase regulator activity	WDR81 IRS1 WASH6P AGAP2	3.68e-05	18	217	4	GO:0035014
GeneOntologyMolecularFunction	chromatin binding	TPR ASH1L SREBF1 GATA4 KDM3B KDM6B ARID1A BAP1 SCML2 NFIA SUPT6H NONO BAHCC1 DNMT3B ZEB1 FOSL2 WBP2NL TSPY26P SIRT2 PKN1	1.72e-04	739	217	20	GO:0003682
GeneOntologyMolecularFunction	histone modifying activity	ASH1L KDM3B KDM6B BAP1 KMT2C BRPF1 HUWE1 SIRT2 PKN1 KDM4B	2.12e-04	229	217	10	GO:0140993
GeneOntologyMolecularFunction	extracellular matrix structural constituent	ACAN FGA COL17A1 FN1 ENAM MUC3A MUC4 MUC5AC TNXB	2.23e-04	188	217	9	GO:0005201
GeneOntologyBiologicalProcess	negative regulation of neurogenesis	PRTG TSC2 BCL11A NFATC4 ULK1 PLXNA3 RTN4 NR1D1 ARHGAP4 SIRT2	1.48e-05	173	216	10	GO:0050768
GeneOntologyBiologicalProcess	heart development	SPEG SYNPO2L MAML1 GATA4 TSC2 KDM6B PPP1R13L ARID1A NFATC4 ACAN FES FN1 ANK2 DYNC2H1 RTN4 APC TENM4 TIE1 NPRL3 LRP1 MESP2 PCNT	1.61e-05	757	216	22	GO:0007507
GeneOntologyBiologicalProcess	negative regulation of nervous system development	PRTG TSC2 BCL11A NFATC4 ULK1 PLXNA3 RTN4 NR1D1 ARHGAP4 SIRT2	2.53e-05	184	216	10	GO:0051961
GeneOntologyBiologicalProcess	regulation of extent of cell growth	BCL11A ULK1 PLXNA3 FN1 RTN4 L1CAM ARHGAP4 LRP1	4.40e-05	122	216	8	GO:0061387
GeneOntologyBiologicalProcess	negative regulation of axonogenesis	TSC2 BCL11A ULK1 PLXNA3 RTN4 ARHGAP4	4.64e-05	62	216	6	GO:0050771
GeneOntologyBiologicalProcess	regulation of small GTPase mediated signal transduction	TRIO SYNPO2L TSC2 GMIP DENND4B RGL2 TNS3 ARHGAP23 RTN4 PSD3 ARHGAP4 DEF6 ARHGAP27	5.27e-05	333	216	13	GO:0051056
GeneOntologyBiologicalProcess	positive regulation of mammary gland epithelial cell proliferation	AGAP2 ZNF703 RTN4	9.08e-05	9	216	3	GO:0033601
GeneOntologyBiologicalProcess	chromatin remodeling	TPR GATAD2A ASH1L KDM3B KDM6B ARID1A INO80D BAP1 KMT2C UBN1 SUPT6H BRPF1 DNMT3B TSPY26P HUWE1 TAF6L SIRT2 PKN1 BICRAL KDM4B	1.09e-04	741	216	20	GO:0006338
GeneOntologyCellularComponent	Golgi lumen	ACAN MUC19 MUC16 MUC5B MUC12 MUC3A MUC4 MUC5AC	1.71e-05	109	215	8	GO:0005796
GeneOntologyCellularComponent	glutamatergic synapse	TRIO TSC2 CSMD2 ZDHHC8 NCDN DLGAP3 NEO1 ACAN AGAP2 RTN4 L1CAM PSD3 APC RPSA GRIN2C GRIN2D SYT10 SIRT2 TENM4 LRP1	3.11e-04	817	215	20	GO:0098978
GeneOntologyCellularComponent	cell-cell junction	ASH1L FRMD4B UBN1 TLN2 WNK4 COL17A1 ANK2 APC CDH24 SIRT2 MICALL2 LMO7 EPHA2 DEF6 PRKCG TNKS1BP1	4.29e-04	591	215	16	GO:0005911
GeneOntologyCellularComponent	anchoring junction	ASH1L FRMD4B UBN1 FES TLN2 WNK4 TNS3 COL17A1 ANK2 RTN4 L1CAM APC CDH24 SIRT2 MICALL2 LMO7 EPHA2 DEF6 LRP1 PRKCG TNKS1BP1 SNTB1	4.82e-04	976	215	22	GO:0070161
GeneOntologyCellularComponent	tight junction	ASH1L FRMD4B UBN1 WNK4 APC MICALL2 EPHA2	5.99e-04	139	215	7	GO:0070160
GeneOntologyCellularComponent	chromatin	GATAD2A SREBF1 GATA4 KDM3B BCL11A ARID1A INO80D SCML2 NFIA NFATC4 NFIC BRPF1 FOXD1 DNMT3B ZEB1 FOSL2 TSPY26P NR1D1 TAF6L SIRT2 OTX1 KANSL1 CCAR2 ELF4 TNKS1BP1 BICRAL MESP2 KDM4B SP7	6.18e-04	1480	215	29	GO:0000785
HumanPheno	Hyperactivity	MANBA TRIO APC2 ASH1L GATA4 KDM3B ZMYM2 TSC2 KDM6B ARID1A BAP1 NFIA MED12L TRAPPC9 TCF20 SZT2 SGSH GRIN2D HUWE1 KANSL1 PRKCG SRRM2 KDM4B PCNT	2.72e-07	558	72	24	HP:0000752
HumanPheno	Disinhibition	MANBA TRIO APC2 ASH1L GATA4 KDM3B ZMYM2 TSC2 BCL11A KDM6B ARID1A BAP1 KMT2C NFIA MED12L NONO TRAPPC9 TCF20 SZT2 SGSH GRIN2D HUWE1 KANSL1 PRKCG SRRM2 KDM4B PCNT	5.91e-06	807	72	27	HP:0000734
HumanPheno	Inappropriate behavior	MANBA TRIO APC2 ASH1L GATA4 KDM3B ZMYM2 TSC2 BCL11A KDM6B ARID1A BAP1 KMT2C NFIA MED12L NONO TRAPPC9 TCF20 SZT2 SGSH GRIN2D HUWE1 KANSL1 PRKCG SRRM2 KDM4B PCNT	5.91e-06	807	72	27	HP:0000719
HumanPheno	Abnormal response to social norms	MANBA TRIO APC2 ASH1L GATA4 KDM3B ZMYM2 TSC2 BCL11A KDM6B ARID1A BAP1 KMT2C NFIA MED12L NONO TRAPPC9 TCF20 SZT2 SGSH GRIN2D HUWE1 KANSL1 PRKCG SRRM2 KDM4B PCNT	5.91e-06	807	72	27	HP:5200123
HumanPheno	Social disinhibition	MANBA TRIO APC2 ASH1L GATA4 KDM3B ZMYM2 TSC2 BCL11A KDM6B ARID1A BAP1 KMT2C NFIA MED12L NONO TRAPPC9 TCF20 SZT2 SGSH GRIN2D HUWE1 KANSL1 PRKCG SRRM2 KDM4B PCNT	5.91e-06	807	72	27	HP:5200029
HumanPheno	Abnormally increased volition	MANBA TRIO APC2 ASH1L GATA4 KDM3B ZMYM2 TSC2 BCL11A KDM6B ARID1A BAP1 KMT2C NFIA MED12L NONO TRAPPC9 TCF20 SZT2 SGSH GRIN2D HUWE1 KANSL1 PRKCG SRRM2 KDM4B PCNT	2.42e-05	869	72	27	HP:5200263
HumanPheno	Macrocephaly	TRIO APC2 ASH1L TSC2 KMT2C NFIA ACAN NONO DNMT3B TCF20 DYNC2H1 L1CAM APC HUWE1 KANSL1 NPRL3 MESP2 SRRM2 SP7	3.20e-05	491	72	19	HP:0000256
HumanPheno	Increased head circumference	TRIO APC2 ASH1L TSC2 KMT2C NFIA ACAN NONO DNMT3B TCF20 DYNC2H1 L1CAM APC HUWE1 KANSL1 NPRL3 MESP2 SRRM2 SP7	4.13e-05	500	72	19	HP:0040194
HumanPheno	Abnormal social development	MANBA TRIO APC2 ASH1L GATA4 KDM3B ZMYM2 TSC2 BCL11A KDM6B ARID1A BAP1 KMT2C NFIA MED12L NONO TRAPPC9 TCF20 SZT2 SGSH GRIN2D HUWE1 KANSL1 PRKCG SRRM2 KDM4B PCNT	5.44e-05	908	72	27	HP:0025732
HumanPheno	Reduced impulse control	IRF2BP2 MANBA TRIO APC2 ASH1L GATA4 KDM3B ZMYM2 TSC2 BCL11A KDM6B ARID1A BAP1 KMT2C NFIA MED12L NONO MN1 TRAPPC9 TCF20 SZT2 SGSH GRIN2D HUWE1 KANSL1 PRKCG SRRM2 KDM4B PCNT	7.22e-05	1032	72	29	HP:5200045
HumanPheno	Attention deficit hyperactivity disorder	TRIO APC2 GATA4 KDM3B ZMYM2 TSC2 BAP1 NFIA MED12L SZT2 GRIN2D KANSL1 PRKCG SRRM2 KDM4B PCNT	1.54e-04	413	72	16	HP:0007018
Domain	PH_dom-like	TRIO IRS1 FRMD4B TLN2 OSBP2 TNS3 AGAP2 ARHGAP23 FRMPD1 PLEKHA4 PSD3 WBP2NL PLEKHA6 DEF6 ARHGAP27 SNTB1	2.42e-05	426	208	16	IPR011993
Domain	VWF_type-D	MUC19 MUC5B MUC4 MUC5AC	2.45e-05	16	208	4	IPR001846
Domain	VWFD	MUC19 MUC5B MUC4 MUC5AC	2.45e-05	16	208	4	PS51233
Domain	VWD	MUC19 MUC5B MUC4 MUC5AC	2.45e-05	16	208	4	SM00216
Domain	VWD	MUC19 MUC5B MUC4 MUC5AC	2.45e-05	16	208	4	PF00094
Domain	fn3	PRTG SPEG NEO1 FN1 L1CAM TIE1 EPHA2 LRRN4 TNXB	8.62e-05	162	208	9	PF00041
Domain	EPHD	KMT2C BRPF1 TCF20 KDM4B	9.34e-05	22	208	4	PS51805
Domain	APC_r	APC2 APC	1.23e-04	2	208	2	PF05923
Domain	SAMP	APC2 APC	1.23e-04	2	208	2	PF05924
Domain	APC_dom	APC2 APC	1.23e-04	2	208	2	IPR026831
Domain	APC_N	APC2 APC	1.23e-04	2	208	2	IPR032038
Domain	APC_basic_dom	APC2 APC	1.23e-04	2	208	2	IPR009234
Domain	Apc_fam	APC2 APC	1.23e-04	2	208	2	IPR026818
Domain	APC_rpt	APC2 APC	1.23e-04	2	208	2	IPR009223
Domain	SAMP	APC2 APC	1.23e-04	2	208	2	IPR009224
Domain	APC_basic	APC2 APC	1.23e-04	2	208	2	PF05956
Domain	APC_N_CC	APC2 APC	1.23e-04	2	208	2	PF16689
Domain	-	TRIO IRS1 FRMD4B TLN2 OSBP2 TNS3 AGAP2 ARHGAP23 PLEKHA4 PSD3 PLEKHA6 DEF6 ARHGAP27 SNTB1	1.30e-04	391	208	14	2.30.29.30
Domain	FN3	PRTG SPEG NEO1 FN1 L1CAM TIE1 EPHA2 LRRN4 TNXB	2.35e-04	185	208	9	SM00060
Domain	PH	TRIO IRS1 OSBP2 AGAP2 PLEKHA4 PSD3 PLEKHA6 DEF6 ARHGAP27 SNTB1	2.56e-04	229	208	10	PF00169
Domain	C8	MUC19 MUC5B MUC5AC	2.78e-04	12	208	3	PF08742
Domain	TIL	MUC19 MUC5B MUC5AC	2.78e-04	12	208	3	PF01826
Domain	PH	TRIO IRS1 OSBP2 AGAP2 ARHGAP23 PLEKHA4 PSD3 PLEKHA6 DEF6 ARHGAP27 SNTB1	2.97e-04	278	208	11	SM00233
Domain	PH_DOMAIN	TRIO IRS1 OSBP2 AGAP2 ARHGAP23 PLEKHA4 PSD3 PLEKHA6 DEF6 ARHGAP27 SNTB1	3.06e-04	279	208	11	PS50003
Domain	PH_domain	TRIO IRS1 OSBP2 AGAP2 ARHGAP23 PLEKHA4 PSD3 PLEKHA6 DEF6 ARHGAP27 SNTB1	3.15e-04	280	208	11	IPR001849
Domain	Unchr_dom_Cys-rich	MUC19 MUC5B MUC5AC	3.59e-04	13	208	3	IPR014853
Domain	C8	MUC19 MUC5B MUC5AC	3.59e-04	13	208	3	SM00832
Domain	K_chnl_volt-dep_ELK	KCNH8 KCNH3	3.68e-04	3	208	2	IPR003950
Domain	Kinase-like_dom	TRIO SPEG PLK5 WDR81 MAP3K12 TESK2 FES DCLK2 ULK1 WNK4 TIE1 EPHA2 PRKCG SRPK3 PKN1 MAP3K2	3.91e-04	542	208	16	IPR011009
Domain	Prot_kinase_dom	TRIO SPEG PLK5 MAP3K12 TESK2 FES DCLK2 ULK1 WNK4 TIE1 EPHA2 PRKCG SRPK3 PKN1 MAP3K2	3.99e-04	489	208	15	IPR000719
Domain	FN3	PRTG SPEG NEO1 FN1 L1CAM TIE1 EPHA2 LRRN4 TNXB	4.02e-04	199	208	9	PS50853
Domain	PROTEIN_KINASE_DOM	TRIO SPEG PLK5 MAP3K12 TESK2 FES DCLK2 ULK1 WNK4 TIE1 EPHA2 PRKCG SRPK3 PKN1 MAP3K2	4.34e-04	493	208	15	PS50011
Domain	TIL_dom	MUC19 MUC5B MUC5AC	4.53e-04	14	208	3	IPR002919
Domain	FN3_dom	PRTG SPEG NEO1 FN1 L1CAM TIE1 EPHA2 LRRN4 TNXB	5.74e-04	209	208	9	IPR003961
Domain	PROTEIN_KINASE_ATP	TRIO SPEG MAP3K12 TESK2 FES DCLK2 ULK1 WNK4 TIE1 EPHA2 PRKCG SRPK3 PKN1 MAP3K2	6.57e-04	459	208	14	PS00107
Domain	CTF_NFI	NFIA NFIC	7.30e-04	4	208	2	PF00859
Domain	CTF_NFI_1	NFIA NFIC	7.30e-04	4	208	2	PS00349
Domain	CTF_NFI_2	NFIA NFIC	7.30e-04	4	208	2	PS51080
Domain	CTF/NFI_DNA-bd-dom	NFIA NFIC	7.30e-04	4	208	2	IPR020604
Domain	NfI_DNAbd_pre-N	NFIA NFIC	7.30e-04	4	208	2	PF10524
Domain	CTF/NFI	NFIA NFIC	7.30e-04	4	208	2	IPR000647
Domain	CTF/NFI_DNA-bd_N	NFIA NFIC	7.30e-04	4	208	2	IPR019548
Domain	CTF/NFI_DNA-bd_CS	NFIA NFIC	7.30e-04	4	208	2	IPR019739
Domain	CH	EHBP1L1 NAV3 SMTN MICALL2 LMO7	7.84e-04	65	208	5	SM00033
Domain	CTCK_1	MUC19 MUC5B MUC5AC	9.82e-04	18	208	3	PS01185
Domain	CH	EHBP1L1 NAV3 SMTN MICALL2 LMO7	1.10e-03	70	208	5	PF00307
Domain	VWC_out	MUC19 MUC5B MUC5AC	1.16e-03	19	208	3	SM00215
Domain	-	EHBP1L1 NAV3 SMTN MICALL2 LMO7	1.17e-03	71	208	5	1.10.418.10
Domain	DUF3504	ZMYM2 ZMYM4	1.21e-03	5	208	2	IPR021893
Domain	DUF3504	ZMYM2 ZMYM4	1.21e-03	5	208	2	PF12012
Domain	CH	EHBP1L1 NAV3 SMTN MICALL2 LMO7	1.33e-03	73	208	5	PS50021
Domain	CH-domain	EHBP1L1 NAV3 SMTN MICALL2 LMO7	1.50e-03	75	208	5	IPR001715
Domain	CT	MUC19 MUC5B MUC5AC	1.79e-03	22	208	3	SM00041
Domain	WxxW_domain	MUC5B MUC5AC	1.80e-03	6	208	2	IPR025155
Domain	Mucin2_WxxW	MUC5B MUC5AC	1.80e-03	6	208	2	PF13330
Domain	SEA	MUC16 MUC12 MUC3A	2.05e-03	23	208	3	PS50024
Domain	SEA_dom	MUC16 MUC12 MUC3A	2.05e-03	23	208	3	IPR000082
Pathway	REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC	MUC16 MUC5B MUC12 MUC3A MUC4 MUC5AC	1.08e-08	16	153	6	M27410
Pathway	REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS	MUC16 MUC5B MUC12 MUC3A MUC4 MUC5AC	1.66e-08	17	153	6	M27412
Pathway	REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS	MUC16 MUC5B MUC12 MUC3A MUC4 MUC5AC	1.28e-07	23	153	6	M556
Pathway	REACTOME_DECTIN_2_FAMILY	MUC16 MUC5B MUC12 MUC3A MUC4 MUC5AC	2.85e-07	26	153	6	M27483
Pathway	REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS	MUC19 MUC16 MUC5B MUC4 MUC5AC	2.49e-06	21	153	5	MM15706
Pathway	REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS	MUC16 MUC5B MUC12 MUC3A MUC4 MUC5AC	5.52e-05	62	153	6	M546
Pathway	REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS	MUC16 MUC5B MUC12 MUC3A MUC4 MUC5AC	9.31e-05	68	153	6	M27303
Pathway	REACTOME_RAC1_GTPASE_CYCLE	TRIO WIPF3 GMIP ARHGAP23 ARHGAP4 EPHA2 DEF6 PKN1 ARHGAP27	1.80e-04	184	153	9	M41809
Pathway	WP_GASTRIC_CANCER_NETWORK_1	GATD3 INO80D APC CEP192	2.23e-04	28	153	4	M39347
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	TRIO SPEG SREBF1 MAML1 KDM3B TSC2 IRS1 KDM6B ARID1A ZDHHC8 BAP1 KMT2C EHBP1L1 UBN1 TLN2 ULK1 RGL2 TRAPPC9 BAHCC1 PLXNA3 SZT2 FOSL2 L1CAM RPSA CEP192 NUP214 GRIN2D HUWE1 ANO8 KCNH3 NHSL1 SIRT2 KANSL1 DNAJC14 DEF6 HELZ2 NPRL3 ZNRF1 TNKS1BP1 PKN1 PRRT4 AHNAK2 PCNT	7.20e-22	1105	219	43	35748872
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	TPR IRF2BP2 KDM3B ZMYM2 BAP1 SPICE1 OTUD7B SCML2 UBN1 NFIA NFIC BRPF1 TLN2 MN1 PRRC2A ZEB1 TCF20 FOSL2 NUP214 HUWE1 NR1D1 SMTN KANSL1 LMO7 HELZ2 CCAR2 TNKS1BP1 PKN1 SRRM2 ZMYM4 KDM4B	2.97e-16	774	219	31	15302935
Pubmed	Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux.	MUC19 MUC16 MUC5B MUC12 MUC3A MUC4 MUC5AC	1.07e-11	18	219	7	18834073
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	TPR TRIO NHSL2 APC2 MCC WDR81 ZMYM2 TSC2 BCL11A NCDN SPICE1 DLGAP3 PTPRN2 TLN2 PRRC2A AGAP2 ZEB1 TCF20 ANK2 APC GRIN2D HUWE1 LRP1 CCAR2 PRKCG PKN1 CNOT1 PCNT	2.00e-11	963	219	28	28671696
Pubmed	Human transcription factor protein interaction networks.	IRF2BP2 GATAD2A MAML1 GATA4 ZMYM2 BCL11A ARID1A INO80D BAP1 KMT2C UBN1 NFIA NFATC4 NFIC PRRC2A TRAPPC9 ZNF703 ZEB1 TCF20 RPSA CEP192 NUP214 MCRIP2 TAF6L KANSL1 MYH14 CCAR2 ELF4 SRRM2 CNOT1 SNTB1 ZMYM4 FILIP1L SP7	2.75e-11	1429	219	34	35140242
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	TRIO KDM3B TSC2 IRS1 SPICE1 MTUS1 TESK2 DCLK2 RGL2 TRAPPC9 WNK4 MACIR TNS3 TCF20 PSD3 APC CEP192 NHSL1 LMO7 PRKCG SRPK3 TNKS1BP1 SRRM2 DOP1A MAP3K2 AHNAK2	4.88e-11	861	219	26	36931259
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SPEG BCL11A CSMD3 NCDN DENND4B NAV3 ULK1 TCF20 FRMPD1 PSD3 CEP192 NUP214 TENM4 KANSL1 CCAR2 SRRM2 PCNT	1.10e-09	407	219	17	12693553
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	KBTBD3 KCNH8 TRIO ASH1L ARID1A ARMC2 MAP3K12 NCDN KMT2C NFIA PTPRN2 SUPT6H NFIC DCLK2 TRAPPC9 FOSL2 FRMPD1 CEP192 HUWE1 ANO8 TESMIN MYH14 EEPD1 LRP1 PKN1 SPIDR CSMD1 CNOT1 ZMYM4 KDM4B DOP1A PCNT	1.40e-09	1489	219	32	28611215
Pubmed	The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4.	IRF2BP2 TRIO ARID1A UBN1 BRPF1 AURKAIP1 PRRC2A TNS3 FOSL2 HUWE1 ABCB10 HELZ2 TNKS1BP1 CNOT1 AHNAK2	3.77e-09	332	219	15	37433992
Pubmed	An improved smaller biotin ligase for BioID proximity labeling.	ASH1L ARID1A ZNF703 TCF20 MUC19 NUP214 CCAR2 ELF4 CNOT1 AHNAK2	6.44e-09	123	219	10	26912792
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	IGSF8 TRIO BCL11A ARID1A NCDN DLGAP3 FGA TLN2 DCLK2 PRRC2A TRAPPC9 AGAP2 FN1 ANK2 ARHGAP23 RTN4 L1CAM PSD3 APC RPSA PLEKHA6 NHSL1 SIRT2 TENM4 UPF2 LMO7 MYH14 PRKCG TNKS1BP1 CNOT1	8.47e-09	1431	219	30	37142655
Pubmed	Expression of Muc19/Smgc gene products during murine sublingual gland development: cytodifferentiation and maturation of salivary mucous cells.	MUC19 MUC16 MUC5B MUC5AC	2.27e-08	6	219	4	19110483
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	MAML1 KDM3B KDM6B FRMD4B BAP1 KMT2C MTUS1 SUPT6H MED12L SZT2 RTN4 ARHGAP4 LMO7 TNKS1BP1 CNOT1 ZMYM4 KDM4B	5.23e-08	529	219	17	14621295
Pubmed	Interaction network of human early embryonic transcription factors.	MAML1 GATA4 ZMYM2 BCL11A ARID1A KMT2C NFIA NFIC BAHCC1 ZNF703 ZEB1 TCF20 NUP214 ZMYM4	5.98e-08	351	219	14	38297188
Pubmed	Human GW182 Paralogs Are the Central Organizers for RNA-Mediated Control of Transcription.	GATAD2A ARID1A KMT2C CCAR2 TNKS1BP1 CNOT1 AHNAK2	9.21e-08	59	219	7	28813667
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	TPR GATAD2A ZMYM2 PPP1R13L ZXDA C18orf21 TLN2 NONO PRRC2A APC PLEKHA6 HUWE1 LMO7 TNKS1BP1 PKN1 SRRM2	1.50e-07	503	219	16	16964243
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	IRF2BP2 MAML1 KDM3B ZMYM2 ARID1A BAP1 SCML2 NFIA NFIC TCF20 FOSL2 TAF6L	1.56e-07	268	219	12	33640491
Pubmed	BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors.	IRF2BP2 KDM3B ZMYM2 ARID1A BAP1 NFIA TCF20 TAF6L CCAR2	1.95e-07	134	219	9	25452129
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	KDM3B BAP1 KMT2C TLN2 PSD3 TENM4 LMO7 HELZ2 TNKS1BP1 KDM4B PCNT	2.16e-07	225	219	11	12168954
Pubmed	Identification of two new members of the CSMD gene family.	CSMD2 CSMD3 CSMD1	2.46e-07	3	219	3	12906867
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	GATD3 TRIO APC2 ASH1L ZMYM2 TSC2 KDM6B ARID1A FRMD4B NAV3 TLN2 DCLK2 PRRC2A AGAP2 FN1 ANK2 APC HUWE1 NR1D1 DNAJC14 LMO7 MYH14 LRP1 ZMYM4 PCNT	6.53e-07	1285	219	25	35914814
Pubmed	Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition.	SREBF1 MAP3K12 NFIC TESK2 FES DCLK2 WNK4 TIE1 EPHA2 PRKCG SRPK3 PKN1 MAP3K2	8.00e-07	372	219	13	22939624
Pubmed	Identification of the SOX2 Interactome by BioID Reveals EP300 as a Mediator of SOX2-dependent Squamous Differentiation and Lung Squamous Cell Carcinoma Growth.	IRF2BP2 GATA4 ZMYM2 ARID1A NFIA NFIC TCF20	9.87e-07	83	219	7	28794006
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	MAML1 ZMYM2 ARID1A UBN1 SUPT6H NONO ZNF703 DYNC2H1 APC CEP192 HUWE1 SIRT2 LMO7 TNKS1BP1 ZMYM4 PCNT	1.18e-06	588	219	16	38580884
Pubmed	Identification and functional characterization of transcriptional activators in human cells.	GATAD2A MAML1 ARID1A KMT2C BAHCC1 ZNF703 ZEB1 TCF20 DYNC2H1 APC FAM90A1 BICRAL KDM4B	1.69e-06	398	219	13	35016035
Pubmed	Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.	TRIO WASH6P SUPT6H NAV3 TLN2 PRRC2A TRAPPC9 FN1 ARHGAP23 PSD3 APC NUP214 TENM4 KANSL1	2.23e-06	475	219	14	31040226
Pubmed	Comprehensive identification of phosphorylation sites in postsynaptic density preparations.	SPEG TSC2 ZDHHC8 FGA PRRC2A AGAP2 RPSA PLEKHA6 GRIN2D SRRM2	2.33e-06	231	219	10	16452087
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	TPR GATAD2A MAML1 GATA4 ZMYM2 BAP1 NFIA NFATC4 NFIC FOXD1 FOSL2 FRMPD1 HUWE1 KANSL1 LRP1 RITA1 CCAR2 SPIDR ZMYM4	2.44e-06	857	219	19	25609649
Pubmed	Polymorphism of human mucin genes in chest disease: possible significance of MUC2.	MUC5B MUC4 MUC5AC	2.44e-06	5	219	3	11062147
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	GATAD2A SREBF1 ZMYM2 ARID1A INO80D BAP1 KMT2C SCML2 UBN1 NFIA SUPT6H NFIC NONO TMEM201 TCF20 FOSL2 NUP214 TAF6L OTX1 KANSL1 LMO7 ELF4 SRRM2 ZMYM4	2.53e-06	1294	219	24	30804502
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	TPR ZMYM2 BAP1 ZEB1 TCF20 APC NUP214 HUWE1 LRP1 TNKS1BP1 CNOT1 ZMYM4 PCNT	2.89e-06	418	219	13	34709266
Pubmed	A genome-wide screen to identify transcription factors expressed in pelvic Ganglia of the lower urinary tract.	SREBF1 BCL11A ARID1A KMT2C NFIA NFATC4 BRPF1 PLXNA3 TCF20 FOSL2 RTN4 NR1D1 OTX1 LMO7 ZNRF1 KDM4B SP7	3.01e-06	709	219	17	22988430
Pubmed	N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.	TPR EHBP1L1 NONO PRRC2A APC LMO7 DEF6 TNKS1BP1 SRRM2 MAP3K2 AHNAK2 PCNT	3.47e-06	360	219	12	33111431
Pubmed	Viral Infection-Induced Differential Expression of LncRNAs Associated with Collagen in Mouse Placentas and Amniotic Sacs.	ATP8A2 TRAPPC9 WNK4 GRAMD1A PLEKHA6 ABCB10 ARHGAP27	3.48e-06	100	219	7	26073538
Pubmed	Biological insights from 108 schizophrenia-associated genetic loci.	GATAD2A WBP1L SREBF1 KDM3B OTUD7B FES TCF20 WBP2NL LRP1 CSMD1 CNOT1	3.98e-06	303	219	11	25056061
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	TPR ARID1A SUPT6H PRRC2A TCF20 FN1 RPSA NUP214 HUWE1 MYH14 HELZ2 CCAR2 TNKS1BP1 SRRM2 CNOT1 PCNT	4.51e-06	653	219	16	22586326
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	IRF2BP2 GATAD2A KDM3B ZMYM2 PPP1R13L UBN1 NONO RTN4 SMTN MYH14 TNKS1BP1 ZMYM4 AHNAK2	5.56e-06	444	219	13	34795231
Pubmed	The Epigenetic Factor Landscape of Developing Neocortex Is Regulated by Transcription Factors Pax6→ Tbr2→ Tbr1.	GATAD2A ASH1L KDM3B KDM6B ARID1A BRPF1 DNMT3B KDM4B	7.44e-06	157	219	8	30186101
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	TRIO PPP1R13L MTUS1 TNS3 APC CEP192 NHSL1 EPHA2 TNKS1BP1	7.84e-06	209	219	9	36779422
Pubmed	Single-cell profiling of epigenetic modifiers identifies PRDM14 as an inducer of cell fate in the mammalian embryo.	KDM3B KDM6B KMT2C DNMT3B KDM4B	8.41e-06	44	219	5	24183668
Pubmed	Human immunodeficiency virus-1 protein Tat induces excitotoxic loss of presynaptic terminals in hippocampal cultures.	GRIN2C GRIN2D LRP1	8.46e-06	7	219	3	23267846
Pubmed	Human immunodeficiency virus protein Tat induces synapse loss via a reversible process that is distinct from cell death.	GRIN2C GRIN2D LRP1	8.46e-06	7	219	3	19036954
Pubmed	Probing nuclear pore complex architecture with proximity-dependent biotinylation.	TPR CSMD3 AURKAIP1 TMEM201 APC NUP214	9.51e-06	77	219	6	24927568
Pubmed	A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.	MAML1 KDM3B WDR81 GMIP PPP1R13L FRMD4B NCDN SPICE1 NFIA NONO MACIR TNS3 RPSA PLEKHA6 SIRT2 UPF2 FKBPL CCAR2 TNKS1BP1 CNOT1	1.05e-05	1038	219	20	26673895
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	TRIO PPP1R13L ARID1A PPM1J SPICE1 MTUS1 PTPRN2 PRRC2A TNS3 ZNF703 GRAMD1A PSD3 CEP192 HUWE1 NHSL1 CCAR2 SRRM2 CNOT1 SNTB1 PCNT	1.22e-05	1049	219	20	27880917
Pubmed	Shotgun sequencing of the human transcriptome with ORF expressed sequence tags.	PLK5 KDM3B MTUS1 NFIC PLXNA3 SZT2 MUC16 PCDHA1 PLEKHA6 LMO7 HELZ2 MUC3A TNXB KDM4B	1.23e-05	552	219	14	10737800
Pubmed	HIV-tat induces formation of an LRP-PSD-95- NMDAR-nNOS complex that promotes apoptosis in neurons and astrocytes.	GRIN2C GRIN2D LRP1	1.35e-05	8	219	3	17360663
Pubmed	A human MAP kinase interactome.	TPR ZMYM2 KMT2C NAV3 RGL2 TCF20 APC NUP214 MUC12 PLEKHA6 KANSL1 BICRAL MAP3K2	1.45e-05	486	219	13	20936779
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	IRF2BP2 GATAD2A MAML1 KDM3B ZMYM2 CSMD2 ARID1A EHBP1L1 NFIA PTPRN2 TCF20 DYNC2H1 MUC16 CNOT1 AHNAK2	1.46e-05	638	219	15	31182584
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	TPR MCC ZMYM2 ARID1A NCDN BAP1 SPICE1 FGA FAM83D TLN2 NONO APC CEP192 NUP214 SMTN KANSL1 MICALL2 CCAR2 TNKS1BP1 CNOT1 ZMYM4	1.49e-05	1155	219	21	20360068
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	SCML2 BRPF1 FAM83D PRRC2A TNS3 ZNF703 RTN4 APC RPSA MCRIP2 UPF2 LMO7 MYH14 EPHA2 CNOT1 AHNAK2	1.62e-05	724	219	16	36232890
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	PIK3AP1 TRIO MAML1 MCC KDM3B PPP1R13L FRMD4B NEO1 SCML2 NFATC4 TNS3 TCF20 APC NUP214 HUWE1 CCAR2	1.88e-05	733	219	16	34672954
Pubmed	Maternal DNA Methylation Regulates Early Trophoblast Development.	SCML2 DNMT3B ZEB1 PLEKHA6	2.78e-05	28	219	4	26812015
Pubmed	New nomenclature for chromatin-modifying enzymes.	ASH1L KDM3B KDM6B KMT2C KDM4B	3.03e-05	57	219	5	18022353
Pubmed	Long-term potentiation modulates synaptic phosphorylation networks and reshapes the structure of the postsynaptic interactome.	TRIO NCDN DLGAP3 TLN2 AGAP2 ANK2 GRIN2D LRP1 PRKCG	3.34e-05	251	219	9	27507650
Pubmed	The multi-subunit GID/CTLH E3 ubiquitin ligase promotes cell proliferation and targets the transcription factor Hbp1 for degradation.	ARID1A SUPT6H BRPF1 NONO GRAMD1A HUWE1 MYH14 CCAR2 CNOT1	3.56e-05	253	219	9	29911972
Pubmed	The transcription factor gene Nfib is essential for both lung maturation and brain development.	NEO1 NFIA NFIC L1CAM	3.69e-05	30	219	4	15632069
Pubmed	Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study.	MUC5B KANSL1 MUC5AC	3.91e-05	11	219	3	24429156
Pubmed	The adenomatous polyposis coli protein is an essential regulator of radial glial polarity and construction of the cerebral cortex.	L1CAM APC PCNT	3.91e-05	11	219	3	19146812
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	TPR TRIO DLGAP3 NEO1 NAV3 TLN2 DCLK2 AGAP2 ANK2 RTN4 GRAMD1A PSD3 APC RPSA HUWE1 ANO8 NHSL1 TENM4 PRKCG CNOT1	3.92e-05	1139	219	20	36417873
Pubmed	Fibrinogen controls human platelet fibronectin internalization and cell-surface retention.	FGA FN1	3.95e-05	2	219	2	17596138
Pubmed	The association between MUC5AC and MUC5B genes expression and remodeling progression in severe neutrophilic asthma: A direct relationship.	MUC5B MUC5AC	3.95e-05	2	219	2	37146737
Pubmed	MUC5AC and MUC5B Mucins Are Decreased in Cystic Fibrosis Airway Secretions.	MUC5B MUC5AC	3.95e-05	2	219	2	14988081
Pubmed	The expression of MUC5AC and MUC5B mucin genes in the mucosa of chronic rhinosinusitis and nasal polyposis.	MUC5B MUC5AC	3.95e-05	2	219	2	17621824
Pubmed	Enhanced discrimination of malignant from benign pancreatic disease by measuring the CA 19-9 antigen on specific protein carriers.	MUC16 MUC5AC	3.95e-05	2	219	2	22220206
Pubmed	Muc5b is required for airway defence.	MUC5B MUC5AC	3.95e-05	2	219	2	24317696
Pubmed	Macrophages are related to goblet cell hyperplasia and induce MUC5B but not MUC5AC in human bronchus epithelial cells.	MUC5B MUC5AC	3.95e-05	2	219	2	22391959
Pubmed	Mucins MUC5AC and MUC5B Are Variably Packaged in the Same and in Separate Secretory Granules.	MUC5B MUC5AC	3.95e-05	2	219	2	35776514
Pubmed	The ocular surface phenotype of Muc5ac and Muc5b null mice.	MUC5B MUC5AC	3.95e-05	2	219	2	24327612
Pubmed	Muc5b is mainly expressed and sialylated in the nasal olfactory epithelium whereas Muc5ac is exclusively expressed and fucosylated in the nasal respiratory epithelium.	MUC5B MUC5AC	3.95e-05	2	219	2	31030254
Pubmed	Essential role of osterix for tooth root but not crown dentin formation.	NFIC SP7	3.95e-05	2	219	2	25349111
Pubmed	Up-regulation of MUC5AC and MUC5B mucin genes in nasopharyngeal respiratory mucosa and selective up-regulation of MUC5B in middle ear in pediatric otitis media with effusion.	MUC5B MUC5AC	3.95e-05	2	219	2	16540890
Pubmed	Basic helix-loop-helix factors recruit nuclear factor I to enhance expression of the NaV 1.4 Na+ channel gene.	NFIC ZEB1	3.95e-05	2	219	2	17936922
Pubmed	Kv12-encoded K+ channels drive the day-night switch in the repetitive firing rates of SCN neurons.	KCNH8 KCNH3	3.95e-05	2	219	2	37516908
Pubmed	Loss of CSMD1 or 2 may contribute to the poor prognosis of colorectal cancer patients.	CSMD2 CSMD1	3.95e-05	2	219	2	24408017
Pubmed	Contribution of mucus concentration and secreted mucins Muc5ac and Muc5b to the pathogenesis of muco-obstructive lung disease.	MUC5B MUC5AC	3.95e-05	2	219	2	27435107
Pubmed	Rare loss of function mutations in N-methyl-D-aspartate glutamate receptors and their contributions to schizophrenia susceptibility.	GRIN2C GRIN2D	3.95e-05	2	219	2	29317596
Pubmed	Mucins MUC5B and MUC5AC in Distal Airways and Honeycomb Spaces: Comparison among Idiopathic Pulmonary Fibrosis/Usual Interstitial Pneumonia, Fibrotic Nonspecific Interstitial Pneumonitis, and Control Lungs.	MUC5B MUC5AC	3.95e-05	2	219	2	26871672
Pubmed	NMDA GluN2C/2D receptors contribute to synaptic regulation and plasticity in the anterior cingulate cortex of adult mice.	GRIN2C GRIN2D	3.95e-05	2	219	2	33766086
Pubmed	DRO1 inactivation drives colorectal carcinogenesis in ApcMin/+ mice.	APC CCDC80	3.95e-05	2	219	2	25053805
Pubmed	Expression of mucins in mucoid otitis media.	MUC5B MUC4	3.95e-05	2	219	2	14690056
Pubmed	The Nfic-osterix pathway regulates ameloblast differentiation and enamel formation.	NFIC SP7	3.95e-05	2	219	2	30091046
Pubmed	Pathobiological implications of mucin (MUC) expression in the outcome of small bowel cancer.	MUC16 MUC5AC	3.95e-05	2	219	2	24722639
Pubmed	Pathophysiological relevance of sputum MUC5AC and MUC5B levels in patients with mild asthma.	MUC5B MUC5AC	3.95e-05	2	219	2	34656442
Pubmed	A calcineurin-dependent transcriptional pathway for cardiac hypertrophy.	GATA4 NFATC4	3.95e-05	2	219	2	9568714
Pubmed	Airway mucin MUC5AC and MUC5B concentrations and the initiation and progression of chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort.	MUC5B MUC5AC	3.95e-05	2	219	2	34058148
Pubmed	Alterations of the ocular surface epithelial MUC16 and goblet cell MUC5AC in patients with atopic keratoconjunctivitis.	MUC16 MUC5AC	3.95e-05	2	219	2	18782111
Pubmed	A novel mouse model of hemangiopericytoma due to loss of Tsc2.	TSC2 FOXD1	3.95e-05	2	219	2	30124871
Pubmed	ARID1A loss in adult hepatocytes activates β-catenin-mediated erythropoietin transcription.	ARID1A APC	3.95e-05	2	219	2	33084574
Pubmed	Histone demethylases KDM4B and KDM6B promotes osteogenic differentiation of human MSCs.	KDM6B KDM4B	3.95e-05	2	219	2	22770241
Pubmed	Mucin production during prenatal and postnatal murine lung development.	MUC5B MUC5AC	3.95e-05	2	219	2	21653907
Pubmed	Enhanced function of NR2C/2D-containing NMDA receptor in the nucleus accumbens contributes to peripheral nerve injury-induced neuropathic pain and depression in mice.	GRIN2C GRIN2D	3.95e-05	2	219	2	35057644
Pubmed	The low density lipoprotein receptor-related protein mediates fibronectin catabolism and inhibits fibronectin accumulation on cell surfaces.	FN1 LRP1	3.95e-05	2	219	2	11867643
Pubmed	NMDA receptors containing GluN2C and GluN2D subunits have opposing roles in modulating neuronal oscillations; potential mechanism for bidirectional feedback.	GRIN2C GRIN2D	3.95e-05	2	219	2	31786200
Pubmed	Mucin deficiency causes functional and structural changes of the ocular surface.	MUC5B MUC5AC	3.95e-05	2	219	2	23272068
Pubmed	Younger patients with COME are more likely to have mucoid middle ear fluid containing mucin MUC5B.	MUC5B MUC5AC	3.95e-05	2	219	2	27729120
Pubmed	De novo NUF2 variant in a novel inherited bone marrow failure syndrome including microcephaly and renal hypoplasia.	MUC5B MUC5AC	3.95e-05	2	219	2	36111525
Pubmed	LRP1 is required for novobiocin-mediated fibronectin turnover.	FN1 LRP1	3.95e-05	2	219	2	30061663
Pubmed	Suppression of intestinal neoplasia by deletion of Dnmt3b.	DNMT3B APC	3.95e-05	2	219	2	16581773
Pubmed	The complement control-related genes CSMD1 and CSMD2 associate to schizophrenia.	CSMD2 CSMD1	3.95e-05	2	219	2	21439553
Interaction	TOP3B interactions	TRIO SPEG SREBF1 MAML1 KDM3B TSC2 IRS1 KDM6B ARID1A ZDHHC8 BAP1 KMT2C EHBP1L1 UBN1 TLN2 ULK1 RGL2 PRRC2A TRAPPC9 BAHCC1 PLXNA3 SZT2 FOSL2 L1CAM PLEKHA4 RPSA CEP192 NUP214 GRIN2D HUWE1 MCRIP2 ANO8 KCNH3 NHSL1 SIRT2 KANSL1 DNAJC14 UPF2 DEF6 HELZ2 NPRL3 ZNRF1 TNKS1BP1 PKN1 CNOT1 PRRT4 AHNAK2 PCNT	1.37e-12	1470	213	48	int:TOP3B
Interaction	NUP43 interactions	GATAD2A ASH1L ZMYM2 ARID1A CSMD3 NFIA SUPT6H AURKAIP1 ZNF703 TCF20 SZT2 MUC19 APC NUP214 SMTN KANSL1 CCAR2 ELF4 SRRM2 CNOT1 ZMYM4 AHNAK2	8.62e-07	625	213	22	int:NUP43
Interaction	FEV interactions	MAML1 GATA4 BCL11A ARID1A BAP1 KMT2C NFIA NFIC ZNF703 ZEB1 TCF20 ZMYM4	1.79e-06	203	213	12	int:FEV
Interaction	YWHAH interactions	TRIO NHSL2 SPEG KDM3B TSC2 IRS1 BAP1 MTUS1 TESK2 DCLK2 RGL2 TRAPPC9 MACIR TNS3 TCF20 FN1 PLEKHA4 PSD3 APC CEP192 HUWE1 NHSL1 LMO7 CCAR2 TNKS1BP1 SRRM2 DOP1A MAP3K2 AHNAK2 PCNT	1.87e-06	1102	213	30	int:YWHAH
Interaction	TLX1 interactions	IRF2BP2 MAML1 ARID1A BAP1 KMT2C NFIA NFIC ZNF703 TCF20 RPSA ZMYM4	2.68e-06	175	213	11	int:TLX1
Interaction	TBR1 interactions	MAML1 ARID1A BAP1 KMT2C NFIA NFIC ZNF703 ZMYM4 SP7	3.21e-06	113	213	9	int:TBR1
Interaction	TBXT interactions	IRF2BP2 MAML1 ARID1A KMT2C NFIA NFIC ZNF703 TCF20 ZMYM4	3.99e-06	116	213	9	int:TBXT
Interaction	CREBBP interactions	GATAD2A SREBF1 MAML1 KDM3B ZMYM2 KDM6B PPP1R13L ARID1A BAP1 NFIA NFATC4 SUPT6H NFIC NONO ZEB1 APC HUWE1 TAF6L CCAR2 SP7	6.12e-06	599	213	20	int:CREBBP
Interaction	YWHAG interactions	NHSL2 SPEG GATA4 MCC KDM3B TSC2 IRS1 BAP1 SPICE1 MTUS1 TESK2 DCLK2 ULK1 RGL2 TRAPPC9 MACIR TNS3 FN1 ARHGAP23 PLEKHA4 PSD3 APC CEP192 HUWE1 NHSL1 LMO7 PRKCG SRRM2 DOP1A MAP3K2 AHNAK2	8.02e-06	1248	213	31	int:YWHAG
Interaction	PAX9 interactions	MAML1 GATA4 BCL11A ARID1A KMT2C NFIA NFIC ZNF703 TCF20	1.01e-05	130	213	9	int:PAX9
Interaction	MEX3A interactions	IRF2BP2 TRIO ARID1A UBN1 BRPF1 AURKAIP1 PRRC2A TNS3 FOSL2 HUWE1 ABCB10 HELZ2 TNKS1BP1 CNOT1 AHNAK2	1.54e-05	384	213	15	int:MEX3A
Interaction	PCK2 interactions	GATD3 ZMYM2 NONO MUC5B EPHA2 PRKCG ZMYM4 AHNAK2	1.82e-05	107	213	8	int:PCK2
Interaction	ERG interactions	MAML1 GATA4 ZMYM2 ARID1A KMT2C NFIA NFIC NONO ZNF703 TCF20 HUWE1	2.66e-05	223	213	11	int:ERG
Interaction	PTK2 interactions	TRIO GATA4 TSC2 IRS1 DLGAP3 NEO1 TNS3 AGAP2 PLEKHA4 APC EPHA2 DEF6 SRRM2	3.26e-05	315	213	13	int:PTK2
Interaction	MAPRE1 interactions	TRIO APC2 PPP1R13L BAP1 MTUS1 NAV3 NONO PRRC2A FN1 PLEKHA4 APC NUP214 LMO7 LRP1 SRRM2 CNOT1 PCNT	3.52e-05	514	213	17	int:MAPRE1
Interaction	SOX6 interactions	IRF2BP2 GATAD2A MAML1 NFIA NFIC PRRC2A ZNF703 TCF20 CCAR2	4.56e-05	157	213	9	int:SOX6
Interaction	ZYX interactions	SPICE1 TLN2 FN1 ANK2 PLEKHA4 PSD3 APC CEP192 LMO7 TNKS1BP1 CNOT1 AHNAK2 PCNT	5.10e-05	329	213	13	int:ZYX
Interaction	AR interactions	TPR IRF2BP2 SREBF1 MAML1 KDM3B ZMYM2 ARID1A BAP1 KMT2C SCML2 NFIA NFIC FES MED12L FAM83D NONO TCF20 FN1 FOSL2 HUWE1 TAF6L MYH14 NPRL3 CCAR2 ZMYM4	5.19e-05	992	213	25	int:AR
Interaction	PAX7 interactions	MAML1 ARID1A KMT2C NFIA NFIC ZNF703 ZEB1 MYH14	5.26e-05	124	213	8	int:PAX7
Interaction	YWHAQ interactions	TPR SPEG TSC2 IRS1 MAP3K12 BAP1 MTUS1 NFATC4 TESK2 FGA DCLK2 RGL2 WNK4 MACIR TNS3 FN1 ARHGAP23 PLEKHA4 PSD3 APC CEP192 NHSL1 LMO7 ZNRF1 CCAR2 DOP1A MAP3K2	5.30e-05	1118	213	27	int:YWHAQ
Interaction	EEF1D interactions	IGSF8 TPR GATA4 KDM6B BAP1 FN1 FOSL2 RTN4 PLEKHA4 APC HUWE1 TNKS1BP1 SRRM2	5.76e-05	333	213	13	int:EEF1D
Interaction	RBBP5 interactions	GATAD2A KDM6B ARID1A KMT2C PLEKHA4 SMTN KANSL1 CCAR2 ELF4 PKN1 SRRM2 KDM4B	5.80e-05	287	213	12	int:RBBP5
Interaction	KDM6A interactions	GATA4 BAP1 KMT2C NFIA NFIC PLEKHA4 KANSL1 ELF4 SP7	5.82e-05	162	213	9	int:KDM6A
Interaction	FMR1 interactions	APC2 MCC BCL11A SPICE1 DLGAP3 PTPRN2 PRRC2A AGAP2 TCF20 PLEKHA4 APC WBP2NL LRP1 CCAR2 PRKCG CNOT1 PCNT	5.91e-05	536	213	17	int:FMR1
Interaction	SMARCA2 interactions	APC2 SREBF1 GATA4 ARID1A NFIA NFIC NONO PLEKHA4 ARHGAP4 ELF4 BICRAL SRRM2 SP7	8.49e-05	346	213	13	int:SMARCA2
Interaction	RMND5A interactions	MAML1 ARID1A SUPT6H WNK4 PLEKHA4 HUWE1 MYH14 CCAR2 CNOT1	1.01e-04	174	213	9	int:RMND5A
Interaction	PFN1 interactions	TPR TRIO WIPF3 BAP1 NONO FN1 ANK2 PLEKHA4 APC CEP192 NHSL1 TNKS1BP1 CNOT1 ZMYM4 AHNAK2 PCNT	1.09e-04	509	213	16	int:PFN1
Interaction	SMARCA4 interactions	SREBF1 MAML1 GATA4 KDM6B ARID1A SCML2 UBN1 NONO ZEB1 PLEKHA4 UPF2 BICRAL SRRM2 KDM4B SP7	1.25e-04	462	213	15	int:SMARCA4
Interaction	DLGAP1 interactions	TRIO NCDN DLGAP3 AGAP2 APC GRIN2C GRIN2D HUWE1 PRKCG	1.30e-04	180	213	9	int:DLGAP1
Interaction	GSK3A interactions	TRIO DDI1 PPP1R13L SPICE1 MTUS1 AURKAIP1 NONO TNS3 PLEKHA4 APC CEP192 NHSL1 PRKCG TNKS1BP1 SRRM2	1.31e-04	464	213	15	int:GSK3A
Interaction	KCTD13 interactions	IGSF8 TRIO BCL11A ARID1A NCDN DLGAP3 FGA TLN2 DCLK2 PRRC2A TRAPPC9 AGAP2 FN1 ANK2 ARHGAP23 RTN4 L1CAM PSD3 APC RPSA PLEKHA6 NHSL1 SIRT2 TENM4 UPF2 LMO7 MYH14 PRKCG TNKS1BP1 CNOT1	1.59e-04	1394	213	30	int:KCTD13
Interaction	HNF4A interactions	IRF2BP2 SREBF1 ZMYM2 ARID1A BAP1 KMT2C UBN1 NFIA MUC19 KANSL1 ZMYM4	1.74e-04	275	213	11	int:HNF4A
Interaction	ZNF252P-AS1 interactions	NCDN INPP4B ARHGAP4 SIRT2	1.76e-04	27	213	4	int:ZNF252P-AS1
Interaction	HNF1B interactions	MAML1 ARID1A BAP1 KMT2C UBN1 NFIA ZEB1 ZMYM4 SP7	1.96e-04	190	213	9	int:HNF1B
GeneFamily	CD molecules\|Mucins	MUC19 MUC16 MUC5B MUC12 MUC3A MUC4 MUC5AC	2.15e-10	21	147	7	648
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	IRS1 OSBP2 AGAP2 ARHGAP23 PLEKHA4 PSD3 PLEKHA6 DEF6 ARHGAP27 SNTB1	7.26e-06	206	147	10	682
GeneFamily	Fibronectin type III domain containing	PRTG NEO1 FN1 L1CAM TIE1 EPHA2 LRRN4 TNXB	4.97e-05	160	147	8	555
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	WDR81 TSC2 UBN1 NONO APC CEP192 PPP1R3A CSMD1	1.18e-04	181	147	8	694
GeneFamily	Rho GTPase activating proteins\|BCH domain containing	GMIP ARHGAP23 ARHGAP4 ARHGAP27	7.23e-04	50	147	4	721
GeneFamily	PHD finger proteins\|Lysine demethylases	KDM3B KDM6B KDM4B	9.40e-04	24	147	3	485
GeneFamily	Zinc fingers MYM-type	ZMYM2 ZMYM4	9.64e-04	6	147	2	86
GeneFamily	Hyalectan proteoglycans\|V-set domain containing\|Sushi domain containing\|C-type lectin domain containing	CSMD2 CSMD3 ACAN CSMD1	1.19e-03	57	147	4	1179
GeneFamily	Glutamate ionotropic receptor NMDA type subunits	GRIN2C GRIN2D	1.34e-03	7	147	2	1201
GeneFamily	PDZ domain containing	SYNPO2L ARHGAP23 FRMPD1 LMO7 SNTB1 AHNAK2	1.53e-03	152	147	6	1220
GeneFamily	C2 domain containing protein kinases	PRKCG PKN1	2.83e-03	10	147	2	835
GeneFamily	WD repeat domain containing\|GRAM domain containing\|BEACH domain containing	GRAMD1A WBP2NL	4.83e-03	13	147	2	1146
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	APC2 ARMC2 APC	5.12e-03	43	147	3	409
GeneFamily	Immunoglobulin lambda locus at 22q11.2	IGLV3-19 IGLV3-12 IGLV3-1 IGLV2-11	6.00e-03	89	147	4	353
GeneFamily	GATA zinc finger domain containing\|Myb/SANT domain containing	GATAD2A GATA4	6.43e-03	15	147	2	82
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	KCNH8 SPEG APC2 TSC2 BCL11A CSMD2 CSMD3 FRMD4B NCDN MTUS1 NAV3 TLN2 DCLK2 PLXNA3 ANK2 ARHGAP23 RTN4 L1CAM MUC19 APC PLEKHA6 ANO8 ZNRF1 CSMD1 PRRT4 DOP1A MAP3K2 AHNAK2 ARMH4	4.74e-08	1106	218	29	M39071
Coexpression	NABA_ECM_AFFILIATED	CLEC5A C1QTNF4 PLXNA3 MUC19 MUC16 MUC5B MUC12 MUC3A MUC4 MUC5AC	1.72e-06	170	218	10	M5880
Coexpression	GSE37605_FOXP3_FUSION_GFP_VS_IRES_GFP_TREG_NOD_DN	PPM1J EHBP1L1 L1CAM TESMIN ZNRF1 ELF4 ARHGAP27 MUC3A FILIP1L AHNAK2	1.81e-06	171	218	10	M8820
Coexpression	FIRESTEIN_CTNNB1_PATHWAY	DCLK2 ULK1 EPHA2 SRPK3 PKN1	6.37e-06	32	218	5	M1489
Coexpression	GSE21670_TGFB_VS_IL6_TREATED_CD4_TCELL_UP	GPR179 NFATC4 PRRC2A ARHGAP23 GRAMD1A MUC16 GRIN2D KANSL1 MESP2 AHNAK2	7.32e-06	200	218	10	M7437
Coexpression	FIGUEROA_AML_METHYLATION_CLUSTER_3_DN	MAML1 PLEKHA4 EPHA2 KDM4B AHNAK2	1.97e-05	40	218	5	M2169
Coexpression	GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_PPARG_KO_TREG_CD4_TCELL_DN	ARID1A INO80D DLGAP3 TRAPPC9 FOSL2 GRAMD1A MUC16 ZNRF1	2.23e-05	139	218	8	M8948
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HDA	BCL11A NCDN MED12L NAV3 PLXNA3 ANK2 ARHGAP23 L1CAM MUC19 MUC16 PLEKHA6 EEPD1 BICRAL CSMD1 ARMH4	2.43e-05	506	218	15	M39067
Coexpression	PEREZ_TP53_TARGETS	MANBA APC2 PLK5 ASH1L WIPF3 MAML1 MCC TSC2 BAP1 SPICE1 BRPF1 FAM83D ULK1 MN1 DNMT3B ARHGAP23 CDH24 MICALL2 LMO7 ELF4 ARHGAP27 MUC5AC KDM4B DOP1A AHNAK2	2.45e-05	1201	218	25	M4391
Coexpression	GSE40655_FOXO1_KO_VS_WT_NTREG_UP	ZMYM2 IRS1 KMT2C UBN1 NFIA SZT2 SGSH HUWE1 PCNT	4.82e-05	200	218	9	M9439
Coexpression	GSE5503_MLN_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_DN	PIK3AP1 APC2 MAML1 ZEB1 DYNC2H1 UPF2 EPHA2 HELZ2 SRRM2	4.82e-05	200	218	9	M291
Coexpression	GSE43863_TH1_VS_LY6C_INT_CXCR5POS_MEMORY_CD4_TCELL_DN	IRF2BP2 ANKS4B NFIC SGSH L1CAM LRP1 TNKS1BP1 BICRAL ARMH4	4.82e-05	200	218	9	M9757
Coexpression	GSE24210_RESTING_TREG_VS_TCONV_UP	MANBA INPP4B SPICE1 FES DCLK2 ZEB1 PSD3 CEP192 BICRAL	4.82e-05	200	218	9	M7839
Coexpression	GSE3203_UNTREATED_VS_IFNB_TREATED_LN_BCELL_DN	DCLK2 OAS2 PLEKHA6 MCRIP2 TENM4 MICALL2 MYH14 DOP1A ARMH4	4.82e-05	200	218	9	M6789
Coexpression	GSE7460_FOXP3_MUT_VS_HET_ACT_TCONV_UP	WDR81 PPM1J FRMD4B EHBP1L1 PTPRN2 MED12L FGA SZT2 DEF6	4.82e-05	200	218	9	M5706
Coexpression	GSE22886_IGA_VS_IGM_MEMORY_BCELL_DN	FCRL2 DCLK2 ULK1 TNS3 AGAP2 DYNC2H1 PLEKHA4 NUP214 EPHA2	4.82e-05	200	218	9	M4439
Coexpression	BILD_HRAS_ONCOGENIC_SIGNATURE	KDM6B KMT2C MTUS1 NAV3 FN1 SMTN EPHA2 ARHGAP27 SRRM2 AHNAK2	5.33e-05	252	218	10	M12029
Coexpression	NABA_ECM_AFFILIATED	CLEC5A C1QTNF4 PLXNA3 MUC19 MUC16 MUC5B MUC4 MUC5AC	5.57e-05	158	218	8	MM17063
Coexpression	ROSS_ACUTE_MYELOID_LEUKEMIA_CBF	TRIO CLEC5A MN1 DNMT3B PSD3 KDM4B	6.39e-05	82	218	6	M7804
Coexpression	HE_LIM_SUN_FETAL_LUNG_C0_MESENCHYMAL_3_CELL	TRIO GATA4 MCC BCL11A MN1 ZEB1 GRAMD1A TENM4	1.09e-04	174	218	8	M45676
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HNBML5	KCNH8 SPEG APC2 BCL11A NCDN PTPRN2 MED12L PLXNA3 ANK2 L1CAM MUC19 APC PLEKHA6	1.52e-04	465	218	13	M39066
Coexpression	CYCLIN_D1_KE_.V1_UP	TRIO TSC2 PRRC2A FOSL2 SMTN EPHA2 PKN1 MUC5AC	1.86e-04	188	218	8	M2648
Coexpression	MARTINEZ_RB1_AND_TP53_TARGETS_DN	TPR MAML1 FRMD4B NCDN NEO1 NFIA SUPT6H ACAN TCF20 HUWE1 NHSL1 TENM4 MYH14 FKBPL ZMYM4	1.95e-04	610	218	15	M3854
Coexpression	GENTILE_UV_RESPONSE_CLUSTER_D5	WBP1L MAML1 NAV3 FOSL2	1.99e-04	35	218	4	M13814
Coexpression	DESCARTES_ORGANOGENESIS_WHITE_BLOOD_CELLS	PIK3AP1 FCRL2 MANBA CLEC5A GMIP TESK2 DENND4B FES DNMT3B OAS2 ARHGAP4 DEF6 HELZ2 ELF4 PKN1	2.13e-04	615	218	15	MM3641
Coexpression	THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN	SREBF1 GMIP ZDHHC8 LILRB1 EHBP1L1 NFIC FES ULK1 LILRA3 GRAMD1A CEP192 TAF6L ARHGAP4 HELZ2 NPRL3 ELF4 ARHGAP27 SRRM2 PCNT	2.17e-04	905	218	19	M40865
Coexpression	UDAYAKUMAR_MED1_TARGETS_DN	TRIO ZMYM2 ZXDA FRMD4B MN1 FOSL2 SMTN ELF4 PCNT	2.18e-04	244	218	9	M9945
Coexpression	MORI_PLASMA_CELL_DN	PIK3AP1 BCL11A TSPY26P SRPK3	2.23e-04	36	218	4	M19509
Coexpression	KAAB_FAILED_HEART_ATRIUM_UP	TRIO ARID1A NCDN FGA	2.23e-04	36	218	4	M8009
Coexpression	SCHERER_PBMC_YF_VAX_AGE_18_40YO_4_TO_7DY_DN	GATD3 DENND4B RGL2 MN1 SGSH RPSA ARHGAP4 LRP1 ARHGAP27	2.25e-04	245	218	9	M41070
Coexpression	NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN	ASH1L KDM6B INO80D LCMT2 EHBP1L1 ACAN BRPF1 TLN2 FN1 FOSL2 L1CAM SMTN TAF6L LRP1 FKBPL ELF4 MUC4 TNXB SNTB1	2.29e-04	909	218	19	M41018
Coexpression	ZHONG_PFC_C3_MICROGLIA	APC2 TSC2 BCL11A CSMD2 CSMD3 NCDN NEO1 NFIA DCLK2 ANK2 TENM4 CSMD1 KDM4B	2.43e-04	488	218	13	M39104
Coexpression	ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN	ARID1A MTUS1 NFIA MN1 DNMT3B TMEM201	2.64e-04	106	218	6	M9160
Coexpression	GSE44649_WT_VS_MIR155_KO_NAIVE_CD8_TCELL_UP	IGSF8 ULK1 ZNF703 ARHGAP23 NHSL1 TENM4 LRP1 SRRM2	2.65e-04	198	218	8	M9778
Coexpression	GSE3982_MAC_VS_NKCELL_DN	ATP8A2 MCC PPP1R13L PCDHGA1 DEF6 ELF4 MUC3A PCNT	2.65e-04	198	218	8	M5509
Coexpression	GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_UP	TSC2 EHBP1L1 SUPT6H NFIC PRRC2A TCF20 SZT2 SRRM2	2.74e-04	199	218	8	M7254
Coexpression	MORI_PLASMA_CELL_DN	PIK3AP1 BCL11A TSPY26P SRPK3	2.75e-04	38	218	4	MM598
Coexpression	GSE15330_HSC_VS_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_UP	TPR ZEB1 COL17A1 OAS2 TIE1 HELZ2 LRP1 ZNRF1	2.83e-04	200	218	8	M7018
Coexpression	GSE2826_WT_VS_BTK_KO_BCELL_UP	TRIO NEO1 PRRC2A ZEB1 SMTN LMO7 SRPK3 MAP3K2	2.83e-04	200	218	8	M4898
Coexpression	GSE27670_BLIMP1_VS_LMP1_TRANSDUCED_GC_BCELL_UP	IGSF8 TSC2 GMIP FES SIRT2 EEPD1 PRKCG SRPK3	2.83e-04	200	218	8	M8209
Coexpression	GSE32986_CURDLAN_LOWDOSE_VS_CURDLAN_HIGHDOSE_STIM_DC_UP	ARID1A UBN1 FES ULK1 MACIR SGSH L1CAM APC	2.83e-04	200	218	8	M8632
Coexpression	GSE26343_UNSTIM_VS_LPS_STIM_MACROPHAGE_DN	PIK3AP1 WDR81 NFIC SGSH L1CAM LRP1 FKBPL AHNAK2	2.83e-04	200	218	8	M8648
Coexpression	GSE3039_NKT_CELL_VS_ALPHAALPHA_CD8_TCELL_UP	ZMYM2 MTUS1 SGSH FOSL2 CCDC80 MICALL2 UPF2 EPHA2	2.83e-04	200	218	8	M6473
Coexpression	GSE40068_BCL6_POS_VS_NEG_CXCR5_POS_TFH_DN	TRIO ZMYM2 KMT2C TCF20 ZNRF1 SRRM2 ZMYM4 FILIP1L	2.83e-04	200	218	8	M9260
Coexpression	ZENG_GU_ICB_CONTROL_METAGENE_31_PRECICTIVE_ICB_RESISTANCE	WIPF3 BCL11A GPR179 C1QTNF4 DNMT3B NHSL1 OTX1 SNTB1	2.93e-04	201	218	8	MM17086
ToppCell	Control-Epithelial_cells-Airway_mucous\|Control / group, cell type (main and fine annotations)	KCNH8 GATA4 PTPRN2 COL17A1 MUC16 MUC5B PLEKHA6 MYH14 EEPD1 MUC3A MUC4 MUC5AC	1.22e-10	183	218	12	15d24a4fb1ffe6cbafbd54fcd7dde9ddcfbe03b2
ToppCell	Control-Epithelial_cells-Airway_goblet\|Control / group, cell type (main and fine annotations)	INPP4B PTPRN2 COL17A1 MUC16 MUC5B PLEKHA6 MYH14 MUC3A MUC4 MUC5AC	2.66e-08	184	218	10	d92a71441e4e19f8c301999d8186f8e48e3cd162
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	EHBP1L1 ARHGAP23 MUC16 NR1D1 MICALL2 MYH14 EPHA2 MUC3A MUC4	2.04e-07	174	218	9	207aa0118633cbe9a65839bbb1bb3ba9f8118ad2
ToppCell	Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	IRF2BP2 CSMD3 KMT2C MUC19 MUC16 TENM4 UPF2 LRP1 CSMD1	3.59e-07	186	218	9	23b8d51d20b05795a73892d3e20e0f9b6a207820
ToppCell	Severe_COVID-19-Epithelial-undefined_Epi\|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30）	IGLV3-19 MUC16 MUC5B PLEKHA6 LMO7 MYH14 EPHA2 MUC4 MUC5AC	4.10e-07	189	218	9	8cbd35320c7e7ff013ef0c0f13f8d875db1c53cd
ToppCell	nucseq\|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MANBA TRIO KMT2C TRAPPC9 TNS3 PLEKHA6 KANSL1 SPIDR ARMH4	4.89e-07	193	218	9	779276e775cb2492e8dd36436295a536084a6415
ToppCell	facs-Heart-RA-18m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GATA4 NFIA NFIC MN1 CCDC80 PLEKHA6 LRP1 PAM TNXB	5.11e-07	194	218	9	bc945450b350f597c3ff910d3a14a533d90086a8
ToppCell	NS-critical-d_07-13\|critical / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	MTUS1 NFIA PSD3 MUC16 CCDC80 OTX1 LMO7 EPHA2 MUC4	6.06e-07	198	218	9	a6e11c87b31beffb6af190c64b4ef3ee1d9dab8d
ToppCell	5'-Adult-Distal_Rectal\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SREBF1 NEO1 WNK4 ZNF703 FN1 MUC5B MUC12 MUC4 TNXB	6.06e-07	198	218	9	db26c20321f9ab102d6484f22ddb2bde684067b1
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_adventitial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NAV3 TLN2 MN1 ZEB1 ANK2 PLEKHA4 CCDC80 LRP1 TNXB	6.59e-07	200	218	9	ad3fdcef895400f929f2ae12ff9bd85fd46adb3a
ToppCell	Tracheal-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NHSL2 ACAN NAV3 ZEB1 FN1 ANK2 CCDC80 LRP1 TNXB	6.59e-07	200	218	9	c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b
ToppCell	5'-Adult-LargeIntestine-Mesenchymal\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NFIA NFIC FN1 CCDC80 LRP1 PAM TNXB FILIP1L AHNAK2	6.59e-07	200	218	9	5a87bb8eb1c6bd2fbc357e1528e15ba1c0051438
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ADGRG4 NAV3 TLN2 MN1 ZEB1 ANK2 CCDC80 LRP1 TNXB	6.59e-07	200	218	9	74e74123ea7bf38d337a3a0248a6a51437c6ab42
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Neuronal-ventral_progenitors_and_neurons_1\|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type.	SYNPO2L CSMD3 NCDN AGAP2 ANK2 L1CAM GPR61 PRRT4	1.60e-06	165	218	8	9795ce31689bc63f5a2d68725ef00b23a90c3846
ToppCell	3'_v3-lymph-node_spleen-Hematopoietic_progenitors-Progenitor\|lymph-node_spleen / Manually curated celltypes from each tissue	BCL11A NFATC4 MED12L C1QTNF4 MN1 BAHCC1 DNMT3B SRPK3	1.75e-06	167	218	8	cb396f3edb9e8fdc316091e8e193dbba50e0be0c
ToppCell	droplet-Heart-nan\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IRF2BP2 WBP1L WIPF3 GATA4 NFIA CCDC80 LRP1 PAM	1.91e-06	169	218	8	2e5bb6437bc9c614e337c5ffb6f6457cd9fc7f4c
ToppCell	PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MUC16 CCDC80 GRIN2C TENM4 LRRN4 TNXB AHNAK2 ARMH4	2.37e-06	174	218	8	a9c6edf5c3fc119c24425f921c5566a8356c30fe
ToppCell	Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)-D231\|Adult / Lineage, Cell type, age group and donor	KCNH8 ATP8A2 C1QTNF4 ANK2 FRMPD1 SYT10 CDH24 TESMIN	2.48e-06	175	218	8	8d9f44a2633b71fb4d2b4a7d9530f954e07c4a18
ToppCell	Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)\|Adult / Lineage, Cell type, age group and donor	KCNH8 ATP8A2 C1QTNF4 ANK2 FRMPD1 SYT10 CDH24 TESMIN	2.48e-06	175	218	8	4db1a3c284488b3f6de7568363f176d74e2a4587
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ULK1 MUC16 MUC5B LMO7 MYH14 EPHA2 MUC4 MUC5AC	2.93e-06	179	218	8	6e965e424eebef50f0202cff75f458be395cfca1
ToppCell	nucseq-Epithelial-Epithelial_Glandular\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	PTPRN2 COL17A1 MUC16 MUC5B MUC3A MUC4 MUC5AC AHNAK2	2.93e-06	179	218	8	859cd8ee414ad6207c046ada2e655e49322dd01c
ToppCell	nucseq-Epithelial-Epithelial_Glandular-Goblet-Goblet\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	PTPRN2 COL17A1 MUC16 MUC5B MUC3A MUC4 MUC5AC AHNAK2	3.05e-06	180	218	8	668a2d8e1d5a390309d5eb62c836f5903144bea9
ToppCell	nucseq-Epithelial-Epithelial_Glandular-Goblet\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	PTPRN2 COL17A1 MUC16 MUC5B MUC3A MUC4 MUC5AC AHNAK2	3.05e-06	180	218	8	3dc80bc636bf0e6ffc9762853132a9fe59fd1f66
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NFIA NAV3 MN1 FN1 CCDC80 LRP1 PAM TNXB	3.32e-06	182	218	8	3dfa9187e9d2bab1d199079d29209c4648220ada
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	NHSL2 INPP4B ZEB1 ANK2 CCDC80 TENM4 SRPK3 CSMD1	3.74e-06	185	218	8	7dcdc009c5681ee05dd18968f7e85c3403fe34af
ToppCell	pdx\|World / Sample and Cell Type and Tumor Cluster (all cells)	GATA4 ARID1A TLN2 TRAPPC9 TCF20 KANSL1 SPIDR SNTB1	3.89e-06	186	218	8	de8e538c8767d41b8a52f5e58ba1affd4e7244c4
ToppCell	pdx-Tumor_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	GATA4 ARID1A TLN2 TRAPPC9 TCF20 KANSL1 SPIDR SNTB1	3.89e-06	186	218	8	0b88a87158a9ca8de3bf40a4ff1687150707a5f0
ToppCell	Hippocampus-Neuronal-Excitatory\|Hippocampus / BrainAtlas - Mouse McCarroll V32	WIPF3 NCDN SUPT6H AGAP2 PSD3 KCNH3 LMO7 PRKCG	4.38e-06	189	218	8	4b90d181eb0a42814eeb23bc82e52fd3a12392a7
ToppCell	droplet-Heart-nan-24m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GATA4 NFIA CCDC80 PLEKHA6 LRP1 PAM TNXB ARMH4	4.73e-06	191	218	8	1f660ea2841324d13f63e01f1789e606c2843fc4
ToppCell	PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TRIO NFIA CCDC80 LRP1 PAM TNXB AHNAK2 ARMH4	4.73e-06	191	218	8	9f478f36a0b895e607e3bb77fa0f9f03cc0f33fc
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive\|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	GATAD2A TRIO KDM6B FGA FOSL2 RTN4 PSD3 EEPD1	4.92e-06	192	218	8	8b86db2ebe0199fee0e9800566a619a24bfdeed5
ToppCell	Adult-Mesenchymal-matrix_fibroblast_2_cell\|Adult / Lineage, Cell type, age group and donor	ADGRG4 NFATC4 NAV3 MN1 ZEB1 ANK2 CCDC80 TNXB	4.92e-06	192	218	8	d21f0f577156f17c899b08871046a26b88aea011
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	WIPF3 DLGAP3 C1QTNF4 L1CAM KCNH3 TENM4 PRKCG CSMD1	5.11e-06	193	218	8	8689a70a33a7c3823dc647d41ac0160e7c3ae396
ToppCell	PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TRIO NFIA CCDC80 LRP1 PAM TNXB AHNAK2 ARMH4	5.11e-06	193	218	8	051f61156b0e2e95292b2d8377faf3190b50f264
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Neuronal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	WIPF3 DLGAP3 C1QTNF4 L1CAM KCNH3 TENM4 PRKCG CSMD1	5.11e-06	193	218	8	be28070c049e7cb68bcd54f582226eb2f5e4bc1c
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	WIPF3 DLGAP3 C1QTNF4 L1CAM KCNH3 TENM4 PRKCG CSMD1	5.11e-06	193	218	8	0c652ebe22ce5d2927599dd97ef1920547858395
ToppCell	Control-Fibroblasts-Intermediate_pathological_FB\|Control / group, cell type (main and fine annotations)	NHSL2 CSMD2 NAV3 DCLK2 FN1 ANK2 CCDC80 TENM4	5.31e-06	194	218	8	03a269f75a481ea54aea8e6444605db8d6df493d
ToppCell	Mesenchymal_cells-Arteriolar_fibro.\|World / Lineage and Cell class	MN1 FN1 ANK2 CCDC80 LRP1 PAM TNXB AHNAK2	5.31e-06	194	218	8	c1e8923a50b4138a1e4c054c0c17b7f7122aa8a9
ToppCell	droplet-Heart-nan-18m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GATA4 NFIA ANK2 CCDC80 PLEKHA6 LRP1 PAM TNXB	5.31e-06	194	218	8	20a0439fa02c5f8107612e34c7ab54120b9b8573
ToppCell	facs-Heart-LA-3m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NFIA MN1 ZEB1 CCDC80 LRP1 PAM TNXB ARMH4	5.51e-06	195	218	8	79a6e8e6de040ff07539e8901fc407363a50e355
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IRF2BP2 ASH1L KMT2C PTPRN2 DYNC2H1 GRIN2C HUWE1 SRRM2	5.51e-06	195	218	8	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	facs-Heart-RA-18m-Mesenchymal-fibroblast_of_cardiac_tissue\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GATA4 NFIA NFIC MN1 CCDC80 LRP1 PAM TNXB	5.51e-06	195	218	8	690d6e15d7c863fc8f2d33b1f7bf86f019f415c9
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IRF2BP2 ASH1L KMT2C PTPRN2 DYNC2H1 GRIN2C HUWE1 SRRM2	5.51e-06	195	218	8	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	facs-Heart-RA-18m-Mesenchymal-fibroblast_of_cardiac_tissue\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GATA4 NFIA NFIC MN1 CCDC80 LRP1 PAM TNXB	5.51e-06	195	218	8	5c05e2bcea3d5d7ebe6325f7187ccf83301053d8
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FAM83D MUC16 MUC5B LMO7 MYH14 EPHA2 MUC4 MUC5AC	5.72e-06	196	218	8	a52879a4c822c5e4be569f01f845a795e00c5f4b
ToppCell	facs-Aorta-Heart-3m-Mesenchymal-fibroblast_of_cardiac_tissue\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NEO1 TNS3 FN1 CCDC80 NR1D1 OTX1 MYH14 TNXB	5.72e-06	196	218	8	2029f58ce6a7b8c35d3a7496c3341391990909ce
ToppCell	facs-Heart-LA-3m-Mesenchymal-fibroblast_of_cardiac_tissue\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NFIA MN1 ZEB1 CCDC80 LRP1 PAM TNXB ARMH4	5.72e-06	196	218	8	ad1838dabd043cb140260843e3527d8c7d58850e
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FAM83D MUC16 MUC5B LMO7 MYH14 EPHA2 MUC4 MUC5AC	5.72e-06	196	218	8	7a4d502550e9e37dc42f2ff1be3c896afe365d7f
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FAM83D MUC16 MUC5B LMO7 MYH14 EPHA2 MUC4 MUC5AC	5.72e-06	196	218	8	60ea673ed887fe3890c5cf4ff4165384b76d7361
ToppCell	facs-Heart-LA-3m-Mesenchymal-fibroblast_of_cardiac_tissue\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NFIA MN1 ZEB1 CCDC80 LRP1 PAM TNXB ARMH4	5.72e-06	196	218	8	cbc15c0769016fe9972445169029bd8d14a7e6ef
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	INPP4B NFIA NFATC4 TNS3 FOXD1 FN1 CCDC80 FILIP1L	5.94e-06	197	218	8	85a8f1d18e0dd1d31341f5131eecd217553bf042
ToppCell	5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MUC16 CCDC80 OTX1 LMO7 MYH14 MUC4 MUC5AC AHNAK2	5.94e-06	197	218	8	5c4cee914baf7cb43e9cb99cc9e3ae823856dc15
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NHSL2 CSMD2 ADGRG4 NAV3 MN1 ZEB1 FN1 LRP1	5.94e-06	197	218	8	0dd71e399f253787fa546a7e90c5373180b89ffd
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	INPP4B NFIA NFATC4 TNS3 FOXD1 FN1 CCDC80 FILIP1L	5.94e-06	197	218	8	e8e3ba791dfaa0fab35e0329a5e34376f9ee6143
ToppCell	3'-Child09-12-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NFIA NFIC FN1 CCDC80 LRP1 PAM TNXB FILIP1L	6.40e-06	199	218	8	a272c54baf8de59c0f259e6498d144a0de8d8924
ToppCell	Bronchial-10x5prime-Epithelial-Epi_airway_secretory\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	FAM83D MUC16 MUC5B OTX1 LMO7 MYH14 MUC4 MUC5AC	6.40e-06	199	218	8	70c0b9cff195d3d24e98443a729e211cac20c90f
ToppCell	NS-critical-LOC-Epithelial\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	NFIA MUC16 CCDC80 LMO7 MYH14 EPHA2 MUC4 MUC5AC	6.40e-06	199	218	8	d64adb68502be596ce55fb2cb63fe1cfa2c5f8ba
ToppCell	Tracheal-NucSeq-Stromal-Peri/Epineurial_\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NHSL2 PLK5 CSMD3 FOXD1 ZEB1 ANK2 PLEKHA4 TNXB	6.40e-06	199	218	8	3835452e4848d7f7dd8651c17b746b271ef39688
ToppCell	(2)_Fibroblasts\|World / Cell class and subclass of bone marrow stroma cells in homeostatis	MN1 FN1 ANK2 CCDC80 LRP1 PAM TNXB AHNAK2	6.40e-06	199	218	8	777423b413376b0d3fbd92ff51dd0133fb54d293
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MANBA CLEC5A KMT2C DENND4B FN1 SZT2 SRRM2 SNTB1	6.40e-06	199	218	8	379bbd9cecf466b902411c54d74bd9885285b1ba
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	FN1 ANK2 DYNC2H1 PSD3 CCDC80 MICALL2 LRP1 TNXB	6.64e-06	200	218	8	9b0916d8d07ac2bf1739f7be5296bf77ffee6094
ToppCell	Control_saline-Mesenchymal_myocytic-Myofibroblastic\|Control_saline / Treatment groups by lineage, cell group, cell type	IRS1 MTUS1 CCDC80 SYT10 SMTN LRP1 TNXB FILIP1L	6.64e-06	200	218	8	9d5b3c2dcfa55d50acc2ce2c319d51aa525d4cd1
ToppCell	5'-Adult-SmallIntestine-Mesenchymal-fibroblastic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NFIA FN1 ANK2 CCDC80 LRP1 PAM TNXB FILIP1L	6.64e-06	200	218	8	3a164e3971bcd62b148b813171c103adb81f972e
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|Control_saline / Treatment groups by lineage, cell group, cell type	FN1 ANK2 PSD3 CCDC80 PLEKHA6 MICALL2 LRP1 TNXB	6.64e-06	200	218	8	bd8cf33502adea320e91ca2af14e1911d88ad374
ToppCell	Parenchymal-10x3prime_v2-Stromal-Peri/Epineurial_-NAF_endoneurial\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	BAP1 SPICE1 TESK2 PLEKHA4 MUC12 MICALL2 DOP1A	7.46e-06	145	218	7	e808502fa52baf1c400f3c9b918a167127e78af9
ToppCell	TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Tubular-6\|TCGA-Stomach / Sample_Type by Project: Shred V9	GATAD2A NR1D1 MYH14 EPHA2 ELF4 SRRM2 MUC4	1.36e-05	159	218	7	655c0749c238bd68cb797adb83e25a23b8a3cc9d
ToppCell	Club-club-7\|World / Class top	IRS1 C18orf21 SYT10 MESP2 ARMH4	1.54e-05	64	218	5	df413c5328966480479c41826461c4d817fbe33d
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	EHBP1L1 ACAN FOXD1 BAHCC1 ZNF703 CCDC80 SRPK3	1.87e-05	167	218	7	4e58f9bf1e9d47720c871776ec34513ded4de9b7
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	EHBP1L1 ACAN FOXD1 BAHCC1 ZNF703 CCDC80 SRPK3	1.87e-05	167	218	7	4ae9f2c5df13463709ea880ab035965fd99e7626
ToppCell	Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)\|Hippocampus / BrainAtlas - Mouse McCarroll V32	WIPF3 NCDN SUPT6H PSD3 KCNH3 LMO7 PRKCG	1.94e-05	168	218	7	6db453cbbbaf4144a86fadcfa5805d33396713b5
ToppCell	E18.5-Immune-Immune_Myeloid-DC-cDC2\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MAML1 WDR81 DENND4B L1CAM CEP192 ANO8 DEF6	1.94e-05	168	218	7	93b7138f17aa14a6398c9b4ea7237781a0e19a66
ToppCell	E18.5-Immune-Immune_Myeloid-DC-cDC2-cDC2_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MAML1 WDR81 DENND4B L1CAM CEP192 ANO8 DEF6	1.94e-05	168	218	7	e393553208617a023f1646169c892a87c95db3f5
ToppCell	10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-E\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	TPR PRTG ZXDA TMEM201 PCDHGA1 NHSL1 DNAJC14	2.02e-05	169	218	7	2833a8a7094e4d407eb923f2bc59b9b112c6bae4
ToppCell	P15-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	CEP295NL ARMC2 FN1 CCDC80 CEP192 TENM4 KDM4B	2.10e-05	170	218	7	ba4ba66b624089ed50a9083176386c7941b4c7a3
ToppCell	10x5'-blood-Myeloid_Dendritic-pDC\|blood / Manually curated celltypes from each tissue	BCL11A PPM1J SCML2 DCLK2 BAHCC1 PHYHD1 EPHA2	2.10e-05	170	218	7	59cb1262ff319349d42b11afbec2a9035b7b79f2
ToppCell	TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-9\|TCGA-Bladder / Sample_Type by Project: Shred V9	IRF2BP2 IRS1 MTUS1 EPHA2 ELF4 TNKS1BP1 MUC4	2.18e-05	171	218	7	adbcfa4bf6bc1c604535a24435924cdb091e2dd7
ToppCell	3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TRIO NFATC4 ANK2 CCDC80 LRP1 TNXB PRRT4	2.26e-05	172	218	7	e37c0b5b547a7345179ab258dd2141fec7064c17
ToppCell	facs-Trachea-nan-24m-Mesenchymal-chondrocyte\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATP8A2 GPR179 ACAN TESK2 FN1 CCDC80 PAM	2.35e-05	173	218	7	2226505610af1becc253d0a5550627144ef0ed6b
ToppCell	PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	GATA4 MUC16 CCDC80 GRIN2C LRRN4 TNXB AHNAK2	2.35e-05	173	218	7	ee7d1429f23f1b89a9a9f7bc07a84a44cf7acd1c
ToppCell	PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	GATA4 MUC16 CCDC80 GRIN2C LRRN4 TNXB AHNAK2	2.35e-05	173	218	7	3725525b99a6011eda2ff5459b4fd2e1eab1f090
ToppCell	PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MUC16 CCDC80 TENM4 LRRN4 TNXB AHNAK2 ARMH4	2.35e-05	173	218	7	30d67738633493d47f06ae452424382f069b6c0a
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_B-B_cell-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	FCRL2 KCNH8 SCML2 MACIR ATG9B PSD3 GRIN2D	2.53e-05	175	218	7	69ed3c7c45df6bef70f5f2ff003531160bf3b32b
ToppCell	PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	GATA4 MUC16 CCDC80 KCNH3 LRRN4 TNXB AHNAK2	2.62e-05	176	218	7	8e7f38de8bf68077e2138f4d06c1f55b0fd096cc
ToppCell	PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	GATA4 MUC16 CCDC80 KCNH3 LRRN4 TNXB AHNAK2	2.62e-05	176	218	7	ed575330a08a6748ea4b28433292c8cfd157d444
ToppCell	droplet-Liver-Npc-18m-Lymphocytic-macrophage/monocyte\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATP8A2 SPICE1 C1QTNF4 BAHCC1 ATG9B SZT2 ARHGAP4	2.82e-05	178	218	7	09d2687e0d79f12e90af35fc1c0453d249cf2d19
ToppCell	ILEUM-non-inflamed-(7)_Lymphatics\|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	MTUS1 NFIA FN1 ANK2 SMTN TIE1 TNXB	2.92e-05	179	218	7	99777a8931356d1206b8ab22aaa1b1d5a600b809
ToppCell	3'-Child04-06-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NFIA NAV3 FN1 CCDC80 APCDD1L PAM TNXB	3.13e-05	181	218	7	e1ae9ada60ec89e7a7cde9c231c1a099ed2ffecc
ToppCell	PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NAV3 OSBP2 FOXD1 CCDC80 LRP1 AHNAK2 ARMH4	3.13e-05	181	218	7	3462aa1c08fbaf613b6278ab2c7a5a0940bf537d
ToppCell	PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NAV3 OSBP2 FOXD1 CCDC80 LRP1 AHNAK2 ARMH4	3.13e-05	181	218	7	6730e249cac55ae892cc567d9211615882f3dab4
ToppCell	COVID-19-Heart-Fib_+_EC_+_Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	NFIA ZEB1 FN1 CCDC80 TENM4 TNXB FILIP1L	3.25e-05	182	218	7	fbd5e332df73bf7141c822fa67b76367dc962017
ToppCell	B_cells-ISG-high_B_cells\|World / Immune cells in Kidney/Urine in Lupus Nephritis	PIK3AP1 BCL11A LILRB1 OAS2 APCDD1L HELZ2 DOP1A	3.36e-05	183	218	7	dc2b00e920efa1dcc2a6265cd1024e3249c9974f
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DDI1 ADGRG4 NAV3 CCDC80 EEPD1 LRP1 TNXB	3.48e-05	184	218	7	e061e85c4bb19f49f6451ddd7a9077d7378ee365
ToppCell	Control-Epithelial-Goblet\|World / Disease state, Lineage and Cell class	MTUS1 MUC5B LMO7 MYH14 EPHA2 MUC4 MUC5AC	3.60e-05	185	218	7	9a793e6016295a63820e9d7563f195494ac692e7
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	MANBA BCL11A INPP4B ZEB1 FN1 CCDC80 TENM4	3.60e-05	185	218	7	1ac6a32cc56d5d819649bdd99518e2ead0eead4c
ToppCell	COVID-19-Heart-Fib_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	NFIA ZEB1 FN1 CCDC80 TENM4 LRP1 TNXB	3.60e-05	185	218	7	8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Gpr149_Islr\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	MISP3 ACAN FRMPD1 SMTN MYH14 FILIP1L	3.67e-05	126	218	6	3539a8fdbb52d191f36dce68c38798ad4d2b491a
ToppCell	COPD-Epithelial-Goblet\|World / Disease state, Lineage and Cell class	MTUS1 MUC16 MUC5B LMO7 MYH14 EPHA2 MUC4	3.73e-05	186	218	7	d75fe7640a4b2c450c9759a1b3c3ef2a087f0092
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SPEG CSMD2 INPP4B ACAN PPP1R3A CSMD1 FILIP1L	3.73e-05	186	218	7	4780af76237d7af2abbe2d8d5530cdf53e3ed0b7
ToppCell	E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MAML1 LCMT2 MACIR ARHGAP23 SZT2 TSPY26P NPRL3	3.86e-05	187	218	7	3699d5e71d779da922920aa3160895db187bf81b
ToppCell	E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MAML1 LCMT2 MACIR ARHGAP23 SZT2 TSPY26P NPRL3	3.86e-05	187	218	7	033ba52c0c2f9978784947098fa697368ae44834
Drug	cellobiitol	GK2 MUC12 EPHA2 MUC3A MUC4 MUC5AC	1.11e-06	37	212	6	CID000003871
Drug	Ketanserin tartrate hydrate [83846-83-7]; Down 200; 7uM; PC3; HT_HG-U133A	TRIO KDM6B MAP3K12 SCML2 MTUS1 PTPRN2 BRPF1 PSD3 APC SRRM2 KDM4B	1.70e-06	189	212	11	6649_DN
Drug	colcemid; Up 200; 11.7uM; MCF7; HT_HG-U133A_EA	TRIO SREBF1 KDM6B NCDN BAP1 DENND4B PRRC2A DNMT3B FN1 NUP214 SMTN	1.79e-06	190	212	11	1103_UP
Drug	Harmaline hydrochloride dihydrate [6027-98-1]; Up 200; 14uM; MCF7; HT_HG-U133A	NCDN NFATC4 AGAP2 BAHCC1 FN1 SGSH PCDHGA1 L1CAM ARHGAP4 TENM4 EPHA2	2.30e-06	195	212	11	2805_UP
Drug	radicicol; Down 200; 0.1uM; PC3; HG-U133A	GATAD2A TRIO SREBF1 BCL11A MAP3K12 EHBP1L1 PTPRN2 NFATC4 ACAN FGA PSD3	2.80e-06	199	212	11	484_DN
Drug	SAHA; Down 200; 10uM; HL60; HT_HG-U133A	CLEC5A KDM3B GMIP ARID1A NFIC FES NAV3 FOSL2 ELF4 SNTB1	6.27e-06	176	212	10	6179_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 1uM; HL60; HT_HG-U133A	CLEC5A BCL11A GMIP ARID1A NFIC FES NAV3 BAHCC1 NPRL3 ELF4	6.93e-06	178	212	10	6193_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 1uM; HL60; HT_HG-U133A	CLEC5A KDM3B BCL11A ARID1A NFIC DENND4B FES NAV3 FOSL2 ELF4	7.28e-06	179	212	10	1175_DN
Drug	clofibrate; Up 200; 150uM; MCF7; HG-U133A	BCL11A ARID1A MAP3K12 SUPT6H TLN2 FOSL2 L1CAM HUWE1 DEF6 SNTB1	1.47e-05	194	212	10	263_UP
Drug	Hesperetin [520-33-2]; Up 200; 13.2uM; MCF7; HT_HG-U133A	KDM6B ARID1A NCDN SUPT6H PRRC2A BAHCC1 PSD3 OAS2 SMTN PKN1	1.61e-05	196	212	10	5350_UP
Drug	Pseudopelletierine hydrochloride [6164-62-1]; Up 200; 21uM; MCF7; HT_HG-U133A	GATAD2A SREBF1 NCDN BAP1 BAHCC1 FOSL2 OAS2 NPRL3 SRRM2 KDM4B	1.68e-05	197	212	10	2766_UP
Drug	Hydroflumethiazide [135-09-1]; Up 200; 12uM; HL60; HT_HG-U133A	MCC INO80D PTPRN2 FN1 FOSL2 APC TAF6L MYH14 SNTB1 DOP1A	1.76e-05	198	212	10	1851_UP
Drug	Remoxipride Hydrochloride [73220-03-8]; Up 200; 9.8uM; MCF7; HT_HG-U133A	MAML1 SUPT6H FGA OSBP2 FRMPD1 OAS2 NUP214 TAF6L DEF6 AHNAK2	1.76e-05	198	212	10	6503_UP
Drug	Alverine citrate salt [5560-59-8]; Up 200; 8.4uM; PC3; HT_HG-U133A	TRIO ASH1L GATA4 ARID1A FOSL2 FRMPD1 PLEKHA6 TAF6L LMO7 BICRAL	1.76e-05	198	212	10	6345_UP
Drug	Oxalamine citrate salt [1949-20-8]; Down 200; 9.2uM; PC3; HT_HG-U133A	TPR TRIO BCL11A INO80D ACAN BRPF1 APC MYH14 LRP1 KDM4B	1.83e-05	199	212	10	6624_DN
Drug	Cefotetan [69712-56-7]; Down 200; 7uM; PC3; HT_HG-U133A	KDM6B MAP3K12 OSBP2 TRAPPC9 FRMPD1 APC NUP214 TAF6L MYH14 ELF4	1.92e-05	200	212	10	3997_DN
Drug	fullerene C60	GATAD2A TRIO APC2 PLK5 ASH1L SREBF1 KDM6B FRMD4B INPP4B EHBP1L1 FES OSBP2 ULK1 RGL2 PRRC2A WNK4 ZNF703 FOSL2 RPSA MUC5B GRIN2D NR1D1 SMTN TAF6L TENM4 TIE1 EEPD1 HELZ2 LRP1 ARHGAP27 MUC4	2.42e-05	1498	212	31	ctd:C069837
Drug	SAHA; Down 200; 10uM; HL60; HT_HG-U133A	CLEC5A BCL11A ARID1A NFIC DENND4B FES NAV3 FOSL2 ELF4	4.03e-05	175	212	9	1161_DN
Drug	gossypolone	TCF20 NUP214 ARHGAP4	6.42e-05	9	212	3	CID005478622
Drug	17-AAG; Down 200; 1uM; PC3; HT_HG-U133A	TSC2 BCL11A MAP3K12 DENND4B DNMT3B SMTN MICALL2 MYH14 KDM4B	7.93e-05	191	212	9	1225_DN
Drug	(+)-Isoproterenol (+)-bitartrate salt [14638-70-1]; Down 200; 11uM; HL60; HT_HG-U133A	GATA4 BCL11A FRMD4B TLN2 ZEB1 FN1 ANK2 SZT2 FOSL2	8.25e-05	192	212	9	3046_DN
Drug	STOCK1N-35215; Down 200; 10uM; PC3; HT_HG-U133A	ZMYM2 BCL11A MAP3K12 COL17A1 SGSH PSD3 TENM4 KDM4B MAP3K2	8.59e-05	193	212	9	6427_DN
Drug	retinoic acid; Down 200; 1uM; PC3; HT_HG-U133A	TSC2 MAP3K12 EHBP1L1 UBN1 SUPT6H DENND4B L1CAM NPRL3 SRRM2	8.93e-05	194	212	9	1211_DN
Drug	Tridihexethyl chloride; Up 200; 11.4uM; MCF7; HT_HG-U133A	GATAD2A SREBF1 NCDN SUPT6H PRRC2A SGSH ARHGAP4 TESMIN SRRM2	8.93e-05	194	212	9	3526_UP
Drug	chlorpromazine hydrochloride; Down 200; 1uM; PC3; HT_HG-U133A	SREBF1 ZMYM2 GMIP KDM6B MAP3K12 PRRC2A NUP214 SMTN SRRM2	8.93e-05	194	212	9	1217_DN
Drug	diclofenac sodium; Down 200; 10uM; MCF7; HG-U133A	GMIP EHBP1L1 ACAN SGSH L1CAM MICALL2 NPRL3 SRPK3 DOP1A	9.29e-05	195	212	9	333_DN
Drug	Acebutolol hydrochloride [34381-68-5]; Up 200; 10.8uM; PC3; HG-U133A	GATD3 SPEG TSC2 GMIP SUPT6H ACAN TLN2 FOSL2 PSD3	9.29e-05	195	212	9	1911_UP
Drug	Dipyridamole [58-32-2]; Down 200; 8uM; HL60; HG-U133A	GATAD2A SREBF1 ZMYM2 INO80D LCMT2 BAP1 FN1 ELF4 KDM4B	9.29e-05	195	212	9	2017_DN
Drug	Phenazopyridine hydrochloride [136-40-3]; Down 200; 16uM; MCF7; HT_HG-U133A	INO80D BAP1 SCML2 SUPT6H PRRC2A DYNC2H1 MYH14 SRRM2 CNOT1	9.29e-05	195	212	9	6234_DN
Drug	Mefexamide hydrochloride [3413-64-7]; Up 200; 12.6uM; PC3; HT_HG-U133A	MANBA MAP3K12 INO80D SCML2 MTUS1 ACAN ULK1 DNMT3B APC	9.29e-05	195	212	9	2121_UP
Drug	PF-00539758-00 [351321-34-1]; Up 200; 10uM; PC3; HT_HG-U133A	MANBA ARID1A MAP3K12 TLN2 TRAPPC9 SZT2 FOSL2 LRP1 MUC5AC	9.29e-05	195	212	9	6379_UP
Drug	Erythromycin [114-07-8]; Up 200; 5.4uM; MCF7; HT_HG-U133A	TRIO KDM6B SUPT6H PSD3 APC PLEKHA6 NR1D1 MAP3K2 FILIP1L	9.29e-05	195	212	9	5329_UP
Drug	Pivmecillinam hydrochloride [32887-03-9]; Down 200; 8.4uM; HL60; HT_HG-U133A	INPP4B MTUS1 PTPRN2 ULK1 ZEB1 DYNC2H1 FOSL2 PAM DOP1A	9.29e-05	195	212	9	2973_DN
Drug	Clomiphene citrate (Z,E) [50-41-9]; Down 200; 6.6uM; PC3; HT_HG-U133A	MCC BCL11A INO80D NCDN MTUS1 TLN2 ZEB1 APC LMO7	9.29e-05	195	212	9	6648_DN
Drug	Piromidic acid [19562-30-2]; Down 200; 13.8uM; MCF7; HT_HG-U133A	GATA4 ZMYM2 KDM6B INO80D BAHCC1 PSD3 APC NR1D1 DEF6	9.29e-05	195	212	9	4398_DN
Drug	Apomorphine hydrochloride hemihydrate [41372-20-7]; Down 200; 6.4uM; HL60; HG-U133A	ZMYM2 FRMD4B NCDN TRAPPC9 PAM ELF4 PKN1 ZMYM4 DOP1A	9.66e-05	196	212	9	2005_DN
Drug	Guaifenesin [93-14-1]; Down 200; 20.2uM; PC3; HT_HG-U133A	MCC ARID1A UBN1 MTUS1 NFIC OSBP2 NR1D1 TAF6L MYH14	9.66e-05	196	212	9	4549_DN
Drug	Propylthiouracil [51-52-5]; Up 200; 23.4uM; MCF7; HT_HG-U133A	TRIO MCC EHBP1L1 TRAPPC9 APC TENM4 MYH14 DEF6 MUC4	9.66e-05	196	212	9	2837_UP
Drug	Denatonium benzoate [3734-33-6]; Down 200; 9uM; PC3; HT_HG-U133A	SPEG SREBF1 ARID1A NCDN OSBP2 FOSL2 APC TAF6L LMO7	9.66e-05	196	212	9	5061_DN
Drug	Penbutolol sulfate [38363-32-5]; Down 200; 5.8uM; HL60; HT_HG-U133A	KDM6B MAP3K12 MTUS1 ULK1 DNMT3B FN1 MICALL2 PAM DOP1A	1.00e-04	197	212	9	2972_DN
Drug	PNU-0251126 [267429-19-6]; Down 200; 1uM; MCF7; HT_HG-U133A	TRIO KDM6B SCML2 ZEB1 PSD3 APC ARHGAP4 MAP3K2 FILIP1L	1.00e-04	197	212	9	4714_DN
Drug	Chloroquine diphosphate [50-63-5]; Up 200; 7.8uM; MCF7; HT_HG-U133A	ARID1A NEO1 SUPT6H BAHCC1 SGSH PCDHGA1 FOSL2 MUC5B NUP214	1.00e-04	197	212	9	2869_UP
Drug	11-deoxy-16,16-dimethyl Prostaglandin E2; Up 200; 10uM; MCF7; HT_HG-U133A	TRIO UBN1 NFATC4 ACAN HUWE1 ARHGAP4 EPHA2 ELF4 MUC5AC	1.00e-04	197	212	9	7514_UP
Drug	Estrone [53-16-7]; Down 200; 14.8uM; HL60; HT_HG-U133A	BCL11A KDM6B INO80D TRAPPC9 BAHCC1 FN1 MYH14 KDM4B DOP1A	1.00e-04	197	212	9	3071_DN
Drug	Piromidic acid [19562-30-2]; Down 200; 13.8uM; MCF7; HT_HG-U133A	MAML1 GMIP SUPT6H PLXNA3 SMTN ELF4 SPIDR SRRM2 MAP3K2	1.00e-04	197	212	9	3335_DN
Drug	Streptozotocin [18883-66-4]; Down 200; 15uM; HL60; HT_HG-U133A	TRIO INO80D MTUS1 TLN2 DYNC2H1 FOSL2 APC OAS2 NR1D1	1.04e-04	198	212	9	2535_DN
Drug	Bicuculline (+) [485-49-4]; Down 200; 10.8uM; HL60; HT_HG-U133A	LILRB1 INO80D ZEB1 DYNC2H1 APC NR1D1 MYH14 NPRL3 SNTB1	1.04e-04	198	212	9	2139_DN
Drug	Mianserine hydrochloride [21535-47-7]; Down 200; 13.2uM; PC3; HT_HG-U133A	MANBA GMIP BAP1 PTPRN2 TENM4 LMO7 NPRL3 SPIDR SRRM2	1.04e-04	198	212	9	5786_DN
Drug	Naringin hydrate [11032-30-7]; Up 200; 6.6uM; MCF7; HT_HG-U133A	SPEG SREBF1 MAML1 NCDN NFATC4 SUPT6H APC NR1D1 TAF6L	1.04e-04	198	212	9	3286_UP
Drug	Acetazolamide [59-66-5]; Up 200; 18uM; HL60; HT_HG-U133A	ASH1L EHBP1L1 MTUS1 NFIC ZEB1 FN1 FOSL2 PSD3 KDM4B	1.04e-04	198	212	9	1850_UP
Drug	Torsemide [56211-40-6]; Down 200; 11.4uM; MCF7; HT_HG-U133A	MANBA TRIO TLN2 TRAPPC9 FN1 APC MYH14 BICRAL SRRM2	1.04e-04	198	212	9	5476_DN
Drug	Mebendazole [31431-39-7]; Down 200; 13.6uM; PC3; HT_HG-U133A	TRIO BCL11A MAP3K12 EHBP1L1 APC DEF6 NPRL3 ZMYM4 DOP1A	1.04e-04	198	212	9	7370_DN
Drug	Azathioprine [446-86-6]; Up 200; 14.4uM; PC3; HT_HG-U133A	KDM6B GK2 SUPT6H TLN2 PLXNA3 FN1 SPIDR SRRM2 SNTB1	1.04e-04	198	212	9	4667_UP
Drug	(1-[(4-Chlorophenyl)phenyl-methyl]-4-methylpiperazine) [1620-21-9]; Up 200; 11.8uM; HL60; HT_HG-U133A	PPP1R13L ARID1A AGAP2 COL17A1 L1CAM APC NR1D1 SMTN TAF6L	1.04e-04	198	212	9	2197_UP
Drug	Fusaric acid [536-69-6]; Down 200; 22.4uM; PC3; HT_HG-U133A	ASH1L TLN2 OSBP2 MN1 BAHCC1 FRMPD1 APC TAF6L MYH14	1.04e-04	198	212	9	3986_DN
Drug	Quinic acid [86-68-0]; Down 200; 19.6uM; MCF7; HT_HG-U133A	ARID1A FRMD4B EHBP1L1 TRAPPC9 ZEB1 PSD3 NR1D1 ELF4 BICRAL	1.04e-04	198	212	9	3540_DN
Drug	Picrotoxinin [17617-45-7]; Down 200; 13.6uM; MCF7; HT_HG-U133A	TRIO BAP1 EHBP1L1 SCML2 SUPT6H NFIC DYNC2H1 PLEKHA6 SMTN	1.04e-04	198	212	9	2816_DN
Drug	Cephalosporanic acid, 7-amino [957-68-6]; Up 200; 14.6uM; MCF7; HT_HG-U133A	TRIO SREBF1 GMIP KDM6B FN1 SZT2 MUC5B ARHGAP4 KDM4B	1.04e-04	198	212	9	3258_UP
Drug	Ethaverine hydrochloride [985-13-7]; Up 200; 9.2uM; MCF7; HT_HG-U133A	MAML1 INO80D BAP1 FOSL2 APC NR1D1 MYH14 ELF4 KDM4B	1.08e-04	199	212	9	5337_UP
Drug	Acetopromazine maleate salt [3598-37-6]; Up 200; 9uM; PC3; HT_HG-U133A	APC2 KDM6B ARID1A NEO1 GK2 NAV3 L1CAM FRMPD1 SPIDR	1.08e-04	199	212	9	4494_UP
Drug	Suramin sodium salt; Up 200; 10uM; MCF7; HT_HG-U133A	TRIO ASH1L ZMYM2 MAP3K12 EHBP1L1 AGAP2 BAHCC1 EPHA2 FILIP1L	1.08e-04	199	212	9	7496_UP
Drug	Fluorocurarine chloride [22273-09-2]; Down 200; 11.6uM; MCF7; HT_HG-U133A	TRIO KDM6B INO80D BRPF1 DYNC2H1 FOSL2 MYH14 ELF4 DOP1A	1.08e-04	199	212	9	6219_DN
Drug	Diclofenac sodium [15307-79-6]; Down 200; 12.6uM; MCF7; HT_HG-U133A	MANBA ASH1L ZMYM2 TSC2 FN1 SMTN EPHA2 BICRAL SPIDR	1.08e-04	199	212	9	7215_DN
Drug	Progesterone [57-83-0]; Up 200; 12.8uM; MCF7; HT_HG-U133A	ATP8A2 SREBF1 FGA ULK1 COL17A1 SZT2 OAS2 NR1D1 AHNAK2	1.08e-04	199	212	9	3287_UP
Drug	Sulconazole nitrate [61318-91-0]; Down 200; 8.6uM; PC3; HT_HG-U133A	SPEG ZMYM2 BCL11A TLN2 ZEB1 APC MYH14 DEF6 LRP1	1.08e-04	199	212	9	6652_DN
Drug	Dosulepin hydrochloride [897-15-4]; Down 200; 12uM; PC3; HT_HG-U133A	MANBA MAP3K12 NCDN SUPT6H NFIC NAV3 BAHCC1 NPRL3 SRRM2	1.08e-04	199	212	9	7284_DN
Drug	Medrysone [2668-66-8]; Up 200; 11.6uM; MCF7; HT_HG-U133A	TRIO BCL11A NFATC4 ACAN TRAPPC9 NUP214 HUWE1 MUC4 SNTB1	1.08e-04	199	212	9	3603_UP
Drug	retinoic acid; Up 200; 1uM; PC3; HT_HG-U133A	TRIO APC2 PTPRN2 TRAPPC9 HUWE1 TAF6L MYH14 SRPK3 MUC4	1.08e-04	199	212	9	4435_UP
Drug	Benzocaine [94-09-7]; Down 200; 24.2uM; HL60; HT_HG-U133A	LILRB1 INO80D TRAPPC9 DNMT3B ZEB1 SGSH NR1D1 TAF6L SNTB1	1.08e-04	199	212	9	2167_DN
Drug	Pheniramine maleate [132-20-7]; Down 200; 11.2uM; PC3; HT_HG-U133A	MANBA KDM6B BAHCC1 SGSH FOSL2 APC OAS2 TAF6L MYH14	1.08e-04	199	212	9	4012_DN
Drug	Iodipamide [606-17-7]; Down 200; 3.6uM; MCF7; HT_HG-U133A	TPR MAP3K12 NCDN PRRC2A DYNC2H1 APC NUP214 NR1D1 SPIDR	1.13e-04	200	212	9	5510_DN
Drug	Ethosuximide [77-67-8]; Up 200; 28.4uM; PC3; HT_HG-U133A	KDM6B ARID1A MAP3K12 NCDN NFATC4 TRAPPC9 LRP1 MUC4 KDM4B	1.13e-04	200	212	9	2116_UP
Drug	17-ethynyl-5-androstene-3, 7, 17-triol	IRS1 SIRT2 LRP1 CNOT1	1.89e-04	31	212	4	ctd:C524733
Disease	Intellectual Disability	TRIO ATP8A2 APC2 ASH1L MCC KDM3B ZMYM2 BCL11A KDM6B KMT2C NFIA MED12L MN1 TCF20 APC GRIN2D KANSL1 PRKCG	2.38e-09	447	203	18	C3714756
Disease	pancreatic ductal carcinoma (is_marker_for)	TSC2 DNMT3B L1CAM MUC5B MUC3A MUC4 MUC5AC	2.09e-07	61	203	7	DOID:3587 (is_marker_for)
Disease	Conventional (Clear Cell) Renal Cell Carcinoma	TSC2 ARID1A CSMD3 INPP4B BAP1 NAV3 DNHD1 L1CAM MUC4	9.29e-07	148	203	9	C0279702
Disease	cholangiocarcinoma (is_marker_for)	OSBP2 MUC16 MUC5B MUC3A MUC4 MUC5AC	5.30e-06	64	203	6	DOID:4947 (is_marker_for)
Disease	Colorectal Carcinoma	APC2 GATA4 MCC ARID1A CSMD3 NCDN KMT2C PTPRN2 FN1 ANK2 RTN4 APC SMTN ABCB10 LMO7 LRP1 ZMYM4	8.12e-06	702	203	17	C0009402
Disease	pulse pressure measurement	GATAD2A WBP1L SYNPO2L KDM6B SUPT6H FES TLN2 TRAPPC9 TNS3 FOXD1 DNMT3B FN1 ANK2 DYNC2H1 FOSL2 PCDHA1 SYT10 TENM4 KANSL1 EEPD1 NPRL3 LRP1 CNOT1 KDM4B FILIP1L	1.18e-05	1392	203	25	EFO_0005763
Disease	risk-taking behaviour	PRTG GATA4 BCL11A ARMC2 INPP4B NEO1 NFIA PTPRN2 NFIC C1QTNF4 MACIR BAHCC1 TCF20 OTX1 TENM4 TNXB ARMH4	2.40e-05	764	203	17	EFO_0008579
Disease	Sarcomatoid Renal Cell Carcinoma	CSMD3 INPP4B BAP1 NAV3 DNHD1 L1CAM MUC4	3.08e-05	128	203	7	C1266043
Disease	Chromophobe Renal Cell Carcinoma	CSMD3 INPP4B BAP1 NAV3 DNHD1 L1CAM MUC4	3.08e-05	128	203	7	C1266042
Disease	Collecting Duct Carcinoma of the Kidney	CSMD3 INPP4B BAP1 NAV3 DNHD1 L1CAM MUC4	3.08e-05	128	203	7	C1266044
Disease	Papillary Renal Cell Carcinoma	CSMD3 INPP4B BAP1 NAV3 DNHD1 L1CAM MUC4	3.08e-05	128	203	7	C1306837
Disease	Renal Cell Carcinoma	CSMD3 INPP4B BAP1 NAV3 DNHD1 L1CAM MUC4	3.08e-05	128	203	7	C0007134
Disease	familial adenomatous polyposis 1 (implicated_via_orthology)	APC2 APC	4.71e-05	2	203	2	DOID:0080409 (implicated_via_orthology)
Disease	Malignant neoplasm of breast	APC2 BCL11A ARID1A INPP4B BAP1 PRRC2A MACIR AGAP2 DNMT3B ZEB1 FN1 ANK2 DYNC2H1 FRMPD1 NUP214 GRIN2D PPP1R3A ABCB10 FKBPL DOP1A	5.69e-05	1074	203	20	C0006142
Disease	resting heart rate	SPEG SREBF1 MAML1 FRMD4B MN1 SYT10 CSMD1	8.09e-05	149	203	7	EFO_0004351
Disease	Parkinson disease	WBP1L ASH1L SREBF1 MED12L MUC19 MUC12 SYT10 KANSL1 PAM ARHGAP27	8.31e-05	321	203	10	MONDO_0005180
Disease	brain small vessel disease (is_implicated_in)	FGA NR1D1	1.41e-04	3	203	2	DOID:0112313 (is_implicated_in)
Disease	keratoconjunctivitis (is_marker_for)	MUC16 MUC5AC	1.41e-04	3	203	2	DOID:9368 (is_marker_for)
Disease	anxiety disorder (biomarker_via_orthology)	DNMT3B L1CAM	1.41e-04	3	203	2	DOID:2030 (biomarker_via_orthology)
Disease	Schizophrenia	SREBF1 BCL11A CSMD2 ZDHHC8 LILRB1 DNMT3B RTN4 PSD3 APC GRIN2C PLEKHA6 GRIN2D TENM4 LRP1 CSMD1 TNXB PCNT	1.41e-04	883	203	17	C0036341
Disease	intellectual disability (implicated_via_orthology)	GATAD2A IRS1 TRAPPC9 ANK2 KANSL1	1.71e-04	75	203	5	DOID:1059 (implicated_via_orthology)
Disease	autosomal dominant intellectual developmental disorder (is_implicated_in)	TRIO SRRM2 KDM4B	2.03e-04	17	203	3	DOID:0060307 (is_implicated_in)
Disease	Acute Myeloid Leukemia, M1	TRIO TSC2 INPP4B KMT2C MN1 NUP214	2.34e-04	125	203	6	C0026998
Disease	Acute Myeloid Leukemia (AML-M2)	TRIO TSC2 INPP4B KMT2C MN1 NUP214	2.34e-04	125	203	6	C1879321
Disease	Central Nervous System Neoplasms	BAP1 APC	2.80e-04	4	203	2	C0085136
Disease	congenital heart disease (biomarker_via_orthology)	GATA4 DNMT3B	2.80e-04	4	203	2	DOID:1682 (biomarker_via_orthology)
Disease	cerebellar ataxia, mental retardation and dysequlibrium syndrome (is_implicated_in)	ATP8A2 WDR81	2.80e-04	4	203	2	DOID:0050997 (is_implicated_in)
Disease	bitter alcoholic beverage consumption measurement	KDM6B INPP4B BAHCC1 MICALL2 CSMD1 ARMH4	3.27e-04	133	203	6	EFO_0010092
Disease	Global developmental delay	APC2 KDM3B MN1 TCF20 SZT2 CNOT1	3.27e-04	133	203	6	C0557874
Disease	Profound Mental Retardation	MCC ZMYM2 KDM6B APC KANSL1 PRKCG	4.14e-04	139	203	6	C0020796
Disease	Mental Retardation, Psychosocial	MCC ZMYM2 KDM6B APC KANSL1 PRKCG	4.14e-04	139	203	6	C0025363
Disease	Mental deficiency	MCC ZMYM2 KDM6B APC KANSL1 PRKCG	4.14e-04	139	203	6	C0917816
Disease	cortical surface area measurement	PRTG ATP8A2 SREBF1 FRMD4B NEO1 NFIA FES NAV3 TLN2 PRRC2A APC RPSA TSPY26P NHSL1 KANSL1 FKBPL PAM ARHGAP27 TNXB SNTB1 SP7	4.16e-04	1345	203	21	EFO_0010736
Disease	alcohol use disorder (implicated_via_orthology)	SREBF1 KDM3B KDM6B ARID1A PSD3 PRKCG SRRM2	4.22e-04	195	203	7	DOID:1574 (implicated_via_orthology)
Disease	Dysequilibrium syndrome	ATP8A2 WDR81	4.65e-04	5	203	2	C0394006
Disease	mucinous adenocarcinoma (is_marker_for)	MUC4 MUC5AC	4.65e-04	5	203	2	DOID:3030 (is_marker_for)
Disease	Klatskin's tumor (is_implicated_in)	ARID1A KMT2C	4.65e-04	5	203	2	DOID:4927 (is_implicated_in)
Disease	plasminogen activator inhibitor 1 measurement	FRMD4B INPP4B NFIC MUC12	5.26e-04	54	203	4	EFO_0004792
Disease	Intrahepatic Cholangiocarcinoma	ARID1A BAP1 KMT2C	5.84e-04	24	203	3	C0345905
Disease	Sjogren's syndrome (is_marker_for)	MUC19 MUC16 MUC5AC	5.84e-04	24	203	3	DOID:12894 (is_marker_for)
Disease	Extrahepatic Cholangiocarcinoma	ARID1A BAP1 KMT2C	5.84e-04	24	203	3	C3805278
Disease	idiopathic pulmonary fibrosis	MUC5B KANSL1 NPRL3 MUC5AC	6.46e-04	57	203	4	EFO_0000768
Disease	Adenoid Cystic Carcinoma	BCL11A KDM6B ARID1A KMT2C KANSL1	6.51e-04	100	203	5	C0010606
Disease	hydrocephalus (is_implicated_in)	WDR81 L1CAM	6.94e-04	6	203	2	DOID:10908 (is_implicated_in)
Disease	Abnormal corpus callosum morphology	MED12L MN1	6.94e-04	6	203	2	C1842581
Disease	Cholangiocarcinoma	ARID1A BAP1 KMT2C	7.42e-04	26	203	3	C0206698
Disease	isthmus cingulate cortex volume measurement	TCF20 WBP2NL TENM4	7.42e-04	26	203	3	EFO_0010310
Disease	Sezary Syndrome	ARID1A KMT2C ZEB1	8.31e-04	27	203	3	C0036920
Disease	lumbar disc degeneration	DYNC2H1 MYH14 CSMD1	9.26e-04	28	203	3	EFO_0004994
Disease	epilepsy (implicated_via_orthology)	TRIO ANK2 L1CAM GRIN2C GRIN2D LRP1	9.56e-04	163	203	6	DOID:1826 (implicated_via_orthology)
Disease	Rectal Neoplasms	MCC APC	9.67e-04	7	203	2	C0034885
Disease	Headache, fasting blood glucose measurement	MANBA GATAD2A	9.67e-04	7	203	2	EFO_0004465, HP_0002315
Disease	biliary tract benign neoplasm (is_marker_for)	MUC4 MUC5AC	9.67e-04	7	203	2	DOID:0050625 (is_marker_for)
Disease	Rectal Carcinoma	MCC APC	9.67e-04	7	203	2	C0007113
Disease	hemoglobin subunit zeta measurement	BCL11A NPRL3	9.67e-04	7	203	2	EFO_0801670
Disease	Alzheimer disease, gastroesophageal reflux disease	GATAD2A SREBF1 PPP1R13L PTPRN2 MACIR PCDHA1 MICALL2	1.06e-03	228	203	7	EFO_0003948, MONDO_0004975
Disease	neuroimaging measurement	PRTG GATAD2A FRMD4B OTUD7B NEO1 NFIA DENND4B NAV3 TLN2 BAHCC1 SZT2 APC RPSA NHSL1 KANSL1 ARHGAP27 KDM4B	1.22e-03	1069	203	17	EFO_0004346
Disease	Prostatic Neoplasms	ASH1L IRS1 ARID1A BAP1 KMT2C NFIC BRPF1 MACIR DNMT3B APC MYH14 MUC4	1.23e-03	616	203	12	C0033578
Disease	Malignant neoplasm of prostate	ASH1L IRS1 ARID1A BAP1 KMT2C NFIC BRPF1 MACIR DNMT3B APC MYH14 MUC4	1.23e-03	616	203	12	C0376358
Disease	Ovarian Mucinous Adenocarcinoma	SPEG ULK1 WNK4	1.25e-03	31	203	3	C1335167
Disease	sickle cell anemia	BCL11A NPRL3	1.28e-03	8	203	2	MONDO_0011382
Disease	common bile duct neoplasm (is_marker_for)	MUC4 MUC5AC	1.28e-03	8	203	2	DOID:4608 (is_marker_for)
Disease	Leukemia, Myelocytic, Acute	TRIO TSC2 INPP4B KMT2C MN1 NUP214	1.30e-03	173	203	6	C0023467
Disease	neutrophil count	ASH1L MAML1 KDM6B ARID1A OTUD7B FES TLN2 TNS3 ARHGAP23 DYNC2H1 PSD3 PCDHA1 TIE1 DEF6 PAM TNXB ZMYM4 KDM4B PCNT SP7	1.44e-03	1382	203	20	EFO_0004833
Disease	intracranial volume measurement	TLN2 SYT10 KANSL1	1.50e-03	33	203	3	EFO_0004886
Disease	stomach cancer (is_implicated_in)	ARID1A KMT2C APC KDM4B	1.55e-03	72	203	4	DOID:10534 (is_implicated_in)
Disease	interleukin 18 receptor accessory protein measurement	FKBPL TNXB	1.64e-03	9	203	2	EFO_0008179
Disease	response to tamoxifen	TCF20 WBP2NL	1.64e-03	9	203	2	EFO_0009391
Disease	Headache, glucose measurement	MANBA GATAD2A	1.64e-03	9	203	2	EFO_0004468, HP_0002315
Disease	interleukin-36 alpha measurement	FKBPL TNXB	1.64e-03	9	203	2	EFO_0021851
Disease	Coffin-Siris syndrome (implicated_via_orthology)	ARID1A BICRAL	1.64e-03	9	203	2	DOID:1925 (implicated_via_orthology)
Disease	serum gamma-glutamyl transferase measurement	PIK3AP1 ASH1L MCC ARID1A CSMD3 ULK1 PRRC2A BAHCC1 DNMT3B ZEB1 FOSL2 PSD3 TENM4 EPHA2 CSMD1	1.74e-03	914	203	15	EFO_0004532
Disease	COVID-19 symptoms measurement	MUC5B KANSL1 MUC5AC	1.79e-03	35	203	3	EFO_0600019
Disease	coronary aneurysm	CSMD2 MESP2 CSMD1	1.79e-03	35	203	3	EFO_1000881
Disease	Inflammatory Bowel Diseases	APC2 MUC19 APC	1.79e-03	35	203	3	C0021390
Disease	medulloblastoma (is_implicated_in)	TSC2 APC	2.04e-03	10	203	2	DOID:0050902 (is_implicated_in)
Disease	response to carboplatin, response to antineoplastic agent	PRTG CSMD1	2.04e-03	10	203	2	GO_0097327, GO_0097328
Disease	glucagon-like peptide-1 measurement	ENAM CSMD1	2.04e-03	10	203	2	EFO_0008465
Disease	dry eye syndrome (is_marker_for)	MUC16 MUC5AC	2.04e-03	10	203	2	DOID:10140 (is_marker_for)
Disease	otitis media (is_marker_for)	MUC5B MUC4	2.04e-03	10	203	2	DOID:10754 (is_marker_for)
Disease	alcohol use disorder measurement, longitudinal alcohol consumption measurement	ZMYM2 DCLK2 BAHCC1	2.10e-03	37	203	3	EFO_0007645, EFO_0009458
Disease	Glioblastoma	MACIR FN1 FOSL2 APC	2.18e-03	79	203	4	C0017636
Disease	ovarian neoplasm	BAP1 MACIR ZEB1 MUC16 KANSL1	2.39e-03	134	203	5	C0919267
Disease	ovarian carcinoma, COVID-19	KANSL1 ARHGAP27	2.49e-03	11	203	2	EFO_0001075, MONDO_0100096
Disease	pulmonary fibrosis	MUC5B MUC5AC	2.49e-03	11	203	2	EFO_0009448
Disease	diet measurement	TRIO WBP1L GATA4 KDM3B BCL11A INPP4B DENND4B DNMT3B TCF20 RTN4 SYT10 SMTN OTX1 TENM4 CSMD1 CNOT1	2.57e-03	1049	203	16	EFO_0008111
Disease	Malignant neoplasm of ovary	BAP1 MACIR ZEB1 MUC16 KANSL1	2.63e-03	137	203	5	C1140680
Disease	reticulocyte measurement	GATAD2A ASH1L IRS1 BCL11A KDM6B TESK2 TLN2 C1QTNF4 MACIR TNS3 GRAMD1A PLEKHA4 KANSL1 EEPD1 NPRL3 ARMH4	2.66e-03	1053	203	16	EFO_0010700
Disease	Giant Cell Glioblastoma	MACIR FN1 FOSL2 APC	2.73e-03	84	203	4	C0334588
Disease	Neoplasm of uncertain or unknown behavior of breast	ARID1A INPP4B BAP1	2.82e-03	41	203	3	C0496956
Disease	Breast adenocarcinoma	ARID1A INPP4B BAP1	2.82e-03	41	203	3	C0858252
Disease	Amelogenesis Imperfecta	COL17A1 ENAM	2.97e-03	12	203	2	C0002452
Disease	congenital diaphragmatic hernia (implicated_via_orthology)	GATA4 LRP1	2.97e-03	12	203	2	DOID:3827 (implicated_via_orthology)
Disease	Malignant neoplasm of liver	TRIO ASH1L BAP1 MACIR APC	3.07e-03	142	203	5	C0345904
Disease	Liver neoplasms	TRIO ASH1L BAP1 MACIR APC	3.07e-03	142	203	5	C0023903
Disease	Childhood Medulloblastoma	SCML2 APC KDM4B	3.23e-03	43	203	3	C0278510
Disease	nasopharynx carcinoma (is_marker_for)	ARID1A KMT2C FOSL2	3.23e-03	43	203	3	DOID:9261 (is_marker_for)
Disease	Melanotic medulloblastoma	SCML2 APC KDM4B	3.23e-03	43	203	3	C1275668
Disease	Medullomyoblastoma	SCML2 APC KDM4B	3.23e-03	43	203	3	C0205833
Disease	Desmoplastic Medulloblastoma	SCML2 APC KDM4B	3.23e-03	43	203	3	C0751291

Protein segments in the cluster

Peptide	Gene	Start	Entry
RNFSGTASTSLLGPP	CCAR2	16	Q8N163
PTFRNGSQTLSPEAG	CEP295NL	441	Q96MC4
GPPGSFLSNSETFLS	COL17A1	891	Q9UMD9
TSASQSFGITDLPPG	BAHCC1	1076	Q9P281
LSLGGFTPNSEPASS	ASH1L	1586	Q9NR48
APRLGSFSGTTVPAL	CSMD1	1866	Q96PZ7
SVTGTQGTLLSPNFP	CSMD2	1101	Q7Z408
RGSSGIISSPSFPNE	CSMD3	246	Q7Z407
VRAGKTFPSSPGDSL	DNMT3B	311	Q9UBC3
PGPLSTFTASQTGLV	ADGRG4	1916	Q8IZF6
FGPASSRTSENRPPS	ARMC2	56	Q8NEN0
FGSSQPERISPESGL	ARMH4	126	Q86TY3
LFIGQRPTDGSSPDT	APCDD1L	426	Q8NCL9
PSSSEVSAVQSPGGR	CCNI2	11	Q6ZMN8
PGPGSSELRSAFSAA	C1QTNF4	21	Q9BXJ3
AAASRVPGSLSPFTG	ABCB10	31	Q9NRK6
ASEIGSAFNSPLRSP	BAP1	496	Q92560
EESSGSSPLPGQFTV	PAM	671	P19021
PRAISAFGPSASING	AGAP2	741	Q99490
NPPSSRSSESGFTEF	DOP1A	591	Q5JWR5
VPSSNFPGSRGSVSS	DNHD1	4606	Q96M86
STSNPIPGDGFSRAT	PIK3AP1	466	Q6ZUJ8
RPPSTHTNGGLTFTA	EEPD1	201	Q7L9B9
TSFPDGLTPEGTQAS	ASTL	36	Q6HA08
SLSSRFSEPSVDQGP	GRAMD1A	586	Q96CP6
TPPTLFRGSSLQQGV	ATP8A2	1141	Q9NTI2
RFPSGSSSPNILASF	CCDC80	131	Q76M96
AQSPTGSDTRLPAFL	ANO8	1011	Q9HCE9
DGGAPTSSPTRRVSF	MUC5B	41	Q9HC84
TGFTVTPSSSPGTAR	MUC5B	3871	Q9HC84
STPSTSPANRFVSVG	NFIA	476	Q12857
PFPFRTGLTSGNVTE	PAAT	256	Q9H8K7
GPGASALARSPFSIE	FOXD1	351	Q16676
QFSDGPIPSPSARSS	PTPRN2	696	Q92932
SGGLFPDARPSTTEK	KBTBD3	281	Q8NAB2
FRVGQSGPECSSSPS	KCNH3	841	Q9ULD8
GSPASVAQSRSGPLS	ARID1A	701	O14497
YLQTPTSSERGGSPI	ANK2	3811	Q01484
TPLSTGGTLAFVSPS	GATAD2A	586	Q86YP4
NLPPSFSEGSGGSRT	OTUD7B	51	Q6GQQ9
FSGIAVPGTSSSRPQ	DDI1	96	Q8WTU0
KRPSGIPERFSGSNS	IGLV3-1	71	P01715
SAGQTFLGPSSAPVS	MAML1	321	Q92585
APGAETTLTSTPGNR	MUC16	1916	Q8WXI7
PPLGSTSQGTFTLDT	MUC16	6741	Q8WXI7
TVDLGTSGTPFSLPS	MUC16	12521	Q8WXI7
TVLSSPSGFNPSGTV	MUC4	351	Q99102
PEIPSFSGLRDSAGT	DNAJC14	31	Q6Y2X3
GLTPPTTERFGQAAT	NONO	426	Q15233
IPQSSGNSSTLGRVP	GPR61	6	Q9BZJ8
GTPRPVVDSYSQSSG	KMT2C	2136	Q8NEZ4
GSRLDPAGSFVPTNT	MED12L	1836	Q86YW9
STSPALQGTPASRGF	NCDN	581	Q9UBB6
RGPSAVSIQAPGSSE	GPR179	1436	Q6PRD1
SQSFHTAGSLPPTGR	MTUS1	181	Q9ULD2
PPGTVIAAFIRTSGT	ELF4	516	Q99607
DSPTSSPGAGTRQLV	GMIP	436	Q9P107
AATELGPRTSPQTGT	FAM90A1	336	Q86YD7
GTSPGTPNRIFFSDI	LRP1	2246	Q07954
GTRDPLFLTGVTFPS	INPP4B	86	O15327
EASPPQSSGLRFSGC	MESP2	366	Q0VG99
SSETFGPAGVRSPTE	KIAA1109	2726	Q2LD37
SAFTSLSPGGRTPSQ	GATD3B	16	A0A0B4J2D5
LGPPASRFSVGTQDS	KDM6B	526	O15054
SSENGSLRFSTPPGE	BCL11A	691	Q9H165
SPTSPGSFRGLKQIS	DCLK2	341	Q8N568
RSPVGSAVGIPQDSS	CDH24	481	Q86UP0
PFTNSGQPESSRGSL	NHSL1	1041	Q5SYE7
FQTSAVPPGTSLSGR	MICALL2	421	Q8IY33
TNGPSSSPGQERELF	MYH14	331	Q7Z406
TFDQVSPSRGPASGG	PLXNA3	936	P51805
NGESRSTLTTLPFPG	MACIR	6	Q96GV9
TTGQSPERSGTTGPF	MUC19	3016	Q7Z5P9
RAAPGTTLVPGSSNT	MUC19	6591	Q7Z5P9
RAAPGTTLAPGSSNT	MUC19	6681	Q7Z5P9
APGRQAGTSVVAPST	MUC19	7566	Q7Z5P9
RGQTTFPSSTATFPE	MUC3A	971	Q02505
KPPSGIGRSTATSSF	NAV3	1051	Q8IVL0
LFPRGTQSTEGSPVS	FAM83D	451	Q9H4H8
GRSLSTPNALSFGSP	NPRL3	436	Q12980
QGTSLRSPVSFSPTD	MAP3K2	291	Q9Y2U5
GPSVGAISTRPQVSS	EHBP1L1	526	Q8N3D4
QGSPGTSYSLDVPRS	PLK5	301	Q496M5
ARGFPASATFQTTPG	PMS2P11	61	Q13670
SDGRTTPQLGSANPS	KANSL1	951	Q7Z3B3
LPSSSQPLTFGSGRS	KDM3B	476	Q7LBC6
SRLSLSTGAPQEPAF	KDM4B	1036	O94953
PFGSQTRGISSLPRS	LMO7	916	Q8WWI1
SSVLPSPSGRSAQGS	NUP214	641	P35658
RGSGPASEFTFSTPE	L1CAM	901	P32004
VFPGTTTRTFCGTPD	PRKCG	506	P05129
QPTATSRGGPTATSV	MUC5AC	1716	P98088
SRSSPSNASAPGTFG	ANKS4B	181	Q8N8V4
STPSATRVGNTVPFG	IRS1	1106	P35568
FNALGQLSSGSTPSP	OAS2	486	P29728
AAGSSEQPRAGSSTP	HUWE1	2876	Q7Z6Z7
VGSATFLRPESGSLP	OSBP2	131	Q969R2
QTAGPVTPASISGRF	PCNT	2361	O95613
IPERFSGSNPGNTAT	IGLV3-12	76	A0A075B6K2
RESSGSESSGQFTPP	OTX1	116	P32242
GLPSGFPTVSLVDST	ACAN	1651	P16112
GFTSQTPEFSGLPSG	ACAN	1886	P16112
AFSPGLSPSLNTSER	PCDHA1	771	Q9Y5I3
SPSSPGQTTSFSRPF	PRTG	1091	Q2VWP7
GFSPQPSRRGSDSSE	PPP1R3A	36	Q16821
PTGSLTQDPARSFGS	NR1D1	56	P20393
RSFGSIPPSLSDDGS	NR1D1	66	P20393
PFPRGAGSSAFSQSS	DERPC	361	P0CG12
PRFSFPGTTGSLAAA	GATA4	106	P43694
PSDAFTFPGQRSSSV	FRMD4B	591	Q9Y2L6
TGRSSQGAVDPSLFP	DYNC2H1	1521	Q8NCM8
SFSLSSGDPGQEAPR	APC2	871	O95996
SVQATGPSSPGRLTS	MCC	286	P23508
SGPPVRLTLASFTQG	FKBPL	181	Q9UIM3
SFGRSVPEAPVGRST	IGSF8	201	Q969P0
LSPGQSSVSQGRPGF	BICRAL	511	Q6AI39
SQSPEGGDPSIFSSL	GK2	516	Q14410
AVTGSASSPEQGRSP	FILIP1L	1006	Q4L180
PDITGYRITTTPTNG	FN1	1201	P02751
SSFSLSSGDPNPDRA	FRMPD1	1011	Q5SYB0
PSTSGSEGVPFRTVS	EPHA2	896	P29317
LVNSPVASPGTEGRS	CCDC191	621	Q8NCU4
LATPAAVSGRPGSSF	DLGAP3	521	O95886
PGSGSAFIPTINAIT	FOSL2	41	P15408
RSLEPPAGLTTSNFS	C17orf80	516	Q9BSJ5
SRIAQDPSSVSPGGT	ATG9B	801	Q674R7
PGDKRPVTSSSFSGF	DEF6	556	Q9H4E7
GDKSRPFITSSPTNG	MANBA	496	O00462
ETRTPSPSFGGFVST	MAP3K12	6	Q12852
SYGTGSETESPRNPS	FGA	276	P02671
VNGRRAPSTSPSFEG	MCRIP2	71	Q9BUT9
EGRFSVPSGSSPGSQ	CEP192	66	Q8TEP8
ERLSDTPGSFQSPSL	DENND4B	1136	O75064
SAFTSLSPGGRTPSQ	GATD3	16	P0DPI2
SSSVLPGLPQTSFSG	INO80D	941	Q53TQ3
AAGPEESTLFPSRNS	ENAM	751	Q9NRM1
LTASSFQPIEGGPVS	FCRL2	111	Q96LA5
EFNRSSVASGPISPT	HELZ2	326	Q9BYK8
SSSSIPEPFGSRGSP	PPP1R13L	71	Q8WUF5
SDFGSSRPAASLAQP	IRF2BP2	131	Q7Z5L9
GPFTSTFANPSRAGL	PPP4R1L	266	Q9P1A2
GKSPASVFRTPTSGQ	C18orf21	156	Q32NC0
PGTSFLGSEPARDNS	PHYHD1	211	Q5SRE7
GSSRAIFSVGPVSPS	LILRA3	176	Q8N6C8
SGPFSASLSLSQLPG	LRRN4	346	Q8WUT4
SALTQPRSVSGSPGQ	IGLV2-11	21	P01706
FTSFGVNPDGSPSSL	UPF2	896	Q9HAU5
TTPGTRVSLPFGQDL	PCDHGA1	146	Q9Y5H4
GLEQVRTPTSSSGAP	MN1	1131	Q10571
LPSVVNGSAFPSGST	TESMIN	281	Q9Y4I5
SGGQSRAISPDSPIS	FES	56	P07332
ATPIAGRFTPGTFTN	RPSA	96	P08865
SFPSTPEGIKDRSGA	RTN4	446	Q9NQC3
FTPGLQGQRPTTTSV	SYNPO2L	471	Q9H987
SLATRFGTGQPAPTA	TAF6L	451	Q9Y6J9
TSESSASFPRSPGQP	SZT2	1641	Q5T011
DTSPPGGVVLSSFRS	RGL2	11	O15211
RLGGSTSDPPSSQSF	SNTB1	221	Q13884
GDAPFSEPGTTSTQR	SRRM2	306	Q9UQ35
GSSRAIFSVGPVSPS	LILRB1	176	Q8NHL6
NRPSGIPDRFSGSSS	IGLV3-19	71	P01714
RSPGESTAPSSLVFT	NHSL2	936	Q5HYW2
SSLRGFPSASATPFG	NFATC4	696	Q14934
PRSPPVANSGSTGFS	PLEKHA4	721	Q9H4M7
SGSAPQSPGASIRTF	NEO1	36	Q92859
SAAGGLRQPSKFSTP	ARHGAP27	541	Q6ZUM4
SFSRPTFLQLSPGGL	PPM1J	66	Q5JR12
TPPTGRSFSGLNSRL	PRRC2A	2076	P48634
GISTSAGIPDFRSPS	SIRT2	86	Q8IXJ6
SANTRGASTPPTLGD	WIPF3	86	A6NGB9
TFSPGASPGSEARTT	PKN1	531	Q16512
PTGSPLSAEFSGTRK	TNS3	966	Q68CZ2
RTPVVTGTGPNFSLG	NFIC	236	P08651
TSDNGIPFPSGRTNL	SGSH	271	P51688
TSVRQGLGPASTTSP	ARHGAP4	886	P98171
NGPQDLRPSTSGVTF	RITA1	221	Q96K30
LNATSGSGRFTPLNP	SPICE1	821	Q8N0Z3
DAGSPFQSSPLSLGS	SREBF1	431	P36956
NQRETGGLLSPSTPF	SRPK3	371	Q9UPE1
GKPSFSRGTFPEDSS	BRPF1	1026	P55201
RLDTGTAGTVAPPQS	AURKAIP1	86	Q9NWT8
PSFGVSAPGRSIEAS	AHNAK2	1996	Q8IVF2
PSFGVSAPGRSIEAS	AHNAK2	3481	Q8IVF2
SSPSGTVAARVTPFN	APC	2771	P25054
FGSSSPSPNGFITTR	CLEC5A	51	Q9NY25
PLSTPNQTTAFSGIG	CNOT1	756	A5YKK6
RGQPASSFSRKGPST	SUPT6H	341	Q7KZ85
SSPEISLRFESGPGA	UHRF1BP1L	1251	A0JNW5
SPSRPGSTAFPSQDG	PLEKHA6	276	Q9Y2H5
TSPLSPFSLVSGSQG	PLEKHA6	701	Q9Y2H5
SSSSSPGDKAGFRVP	ZNF703	181	Q9H7S9
FKEPTPSLTASRGDG	MISP3	181	Q96FF7
SGPSLAGTAESRPQT	SPEG	361	Q15772
AASLTVRPGGSTSPF	SPEG	806	Q15772
QDFSRSVPGTTSSPL	SCML2	571	Q9UQR0
TSSSQSVAPRPGAGL	SPIDR	326	Q14159
APFTSTNGLLSPAGS	SP7	66	Q8TDD2
SGGRSVPTTPLQVAA	TPR	2206	P12270
PRLNPASAFGSSTDS	THEM5	26	Q8N1Q8
SPLVSFSGDGPISTV	TIE1	466	P35590
GTSPSSPTFTFTLGR	ARHGAP23	581	Q9P227
ESFSSLPPLGSQGLS	SOGA1	506	O94964
SFGTRPLSSGFSPEE	TNKS1BP1	976	Q9C0C2
GQSLLPPVSTSFTTG	TNXB	4006	P22105
SPAGSGARPQESTAA	WBP2NL	276	Q6ICG8
GTTLSPLRNFSGLSP	PRRT4	221	C9JH25
QSRGTVPPSSHETGF	TENM4	516	Q6N022
SGSRPPSQVSRSGEF	TMEM201	471	Q5SNT2
SAAGPGFTSRTEPSK	TCF20	686	Q9UGU0
GFTSRTEPSKSPGSL	TCF20	691	Q9UGU0
LPGRATSFDSQGSCP	SYT10	501	Q6XYQ8
SPVLPVGSTTNGSRS	ZEB1	686	P37275
VGNSFSGPANPLVSR	ZMYM2	31	Q9UBW7
EASTASRGPGPSLFA	ZXDA	61	P98168
SVGQATSRPVPSSAG	UBN1	941	Q9NPG3
PTSGEPRQTVLTAAG	TLN2	631	Q9Y4G6
FSSDLQTPRPGSAES	ZDHHC8	326	Q9ULC8
DGISVSGFPLSSPFR	TRAPPC9	811	Q96Q05
SPSGVFPASVVSSEG	LCMT2	336	O60294
PGTPSQTRSFRSAGL	PRR30	351	Q53SZ7
ERPAGSTPATFSTSG	TESK2	546	Q96S53
AFPSPGRGEAASTAT	TSPY26P	51	Q9H489
SEGRLKPSASFGSPV	UHRF1BP1	746	Q6BDS2
KAPSERPGTSSGTFS	PSD3	366	Q9NYI0
PFPFRTGLTSGNVTE	nan	91	Q499Y3
DGSSSASPSVQGAPR	WASH6P	321	Q9NQA3
SAFALSIPRSGPGSD	WNK4	621	Q96J92
RGSQGAQSSPLSEPS	WBP1L	151	Q9NX94
PLASGPSSFQRAGSV	SMTN	316	P53814
ARAGGTSSPSPVVFT	ULK1	741	O75385
TVSSGESPPLSAGNI	WDR81	1266	Q562E7
FSVSGSPLAPQLTTG	ZMYM4	301	Q5VZL5
STAARSRGPFPGVST	ZNRF1	6	Q8ND25
RPGSFTFPGDSDSLQ	TRIO	2496	O75962
ASQFLGSATSPGPRT	TSC2	1146	P49815
VDPSSVGSSPQRTGA	KCNH8	961	Q96L42
SPGATGTALFPTRSA	MUC12	1641	Q9UKN1
SPGATGTALFPTRSA	MUC12	4281	Q9UKN1
NGITPLPAHFTTSGR	MUC12	4836	Q9UKN1
ARSNGTVSPSAFLEP	GRIN2C	536	Q14957
ARSNGTVSPSAFLEP	GRIN2D	566	O15399